Document:

Exhibit 4.13

 

SECURITIES PURCHASE
AGREEMENT

 

This SECURITIES PURCHASE
AGREEMENT (the “Agreement”) is made as of November 18, 2021, by
and among SENTIENT BRANDS HOLDINGS INC., a Nevada corporation (the “Company”), and LEONITE
FUND I, LP, a Delaware limited partnership (the “Purchaser”).

 

Recital

 

A.           
The Company and the Purchaser are executing and delivering this Agreement in reliance
upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”), and/or Regulation D promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the Securities Act;

 

B.          
The Purchaser desires to purchase from the Company, and the Company desires to issue
and sell to the Purchaser, upon the terms and conditions set forth in this Agreement, a Senior Secured Convertible Promissory Note
of the Company, in the aggregate principal amount of four hundred thousand Dollars ($400,000) , in the form attached hereto as
Exhibit A (the “Note”), upon the terms and subject to the limitations and conditions set forth in such
Note;

 

C.          
Company wishes to issue to the Purchaser, as additional consideration for the purchase
of the Note, a Warrant (as defined below) to acquire 666,667 Common Shares (as defined in the Note), in the form attached hereto
as Exhibit B (the “Warrant”), as further provided herein. 

 

Agreement

 

Now,
Therefore, in consideration of the foregoing, and the representations, warranties, covenants and conditions set forth
below, the Company and the Purchaser, intending to be legally bound, hereby agree as follows:

 

	1.	Amount and Terms of the Note; Warrant

 

1.1             
Purchase of the Note. Subject to the terms of this
Agreement, for consideration of an aggregate principal amount of four hundred thousand Dollars ($400,000) in cash (the “Consideration”),
to be paid by Purchaser to the Company in two (2) tranches of two hundred thousand Dollars ($200,000) each, with the first $200,000
tranche (the “Initial Tranche”) to be paid to the Company on the Issue Date (as defined in the Note) (the “Initial
Closing Date”), less $5,000 which Purchaser shall retain to cover its legal fees, and the second $200,000 tranche (the
“Final Tranche”) to be paid to the Company within 30 days after the Issue Date (the “Final Closing
Date” and together with the Initial Closing Date, the “Closing Dates”), Purchaser agrees to subscribe
for and purchase from the Company , and the Company agrees
to issue and sell to Purchaser, the
Note, subject to the satisfaction (or written
waiver) of the conditions set forth in Section 6 and Section 7 below. 

 

    	1

    	 

    

 

1.2        
Warrant. The Warrant shall be issued to Purchaser
on the Final Closing Date and shall be exercisable for a period of five (5) years at an exercise price of forty-five cents ($0.45)
per share.

 

1.3        
Form of Payment. On
the Closing Dates, the
Purchaser shall pay
to the Company the Consideration as set forth in section 1.1 above. 

 

	2.	Closing and Delivery

 

2.1             
Closings. The closings of the transactions contemplated
by this Agreement (collectively, the “Closing”) shall occur on the Closing Dates, at such location as may be
agreed to by the parties (including via exchange of electronic signatures).

 

2.2             
Delivery. 

 

(a)On the
Initial Closing Date, Purchaser shall pay and deliver the Initial Tranche to the Company, and the Company shall issue and deliver
the Note to Purchaser.

 

(b)On the
Final Closing Date, Purchaser shall pay and deliver the Final Tranche to the Company, and the Company shall issue and deliver to
the Purchaser the Warrant.

 

	3.	Representations and Warranties of the Company

 

Except as set forth in
the corresponding section of the Disclosure Schedule (as defined below) delivered to the Purchaser concurrently herewith and attached
hereto as Schedule I (the “Disclosure Schedule”) or as disclosed in the Disclosure Materials (as defined
below), the Company, its Subsidiaries (as defined below), Officers and Directors hereby makes the following representations and
warranties as of the date hereof and as of the Initial Closing Date to the Purchaser:

 

3.1             
Organization, Good Standing and Qualification. The
Company and each of its Subsidiaries is a corporation or limited liability company duly organized, validly existing and in good
standing under the laws of its jurisdiction of incorporation or organization. Each of the Company and its Subsidiaries has the
requisite corporate power to own and operate its properties and assets and to carry on its business as now conducted and as proposed
to be conducted. The Company and each of its Subsidiaries is duly qualified and is authorized to do business and is in good standing
as a foreign corporation in all jurisdictions in which the nature of its activities and of its properties (both owned and leased)
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would
not have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability of any
Subscription Document (as defined below), (ii) a material adverse effect on the results of operations, assets, business or financial
condition of Company and the Subsidiaries, taken as a whole, or (iii) adversely impair the Company’s ability to perform in
any material respect on a timely basis its obligations under any Subscription Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”).

 

    	2

    	 

    

 

3.2             
Corporate Power. The Company has all requisite
corporate power to execute and deliver this Agreement, and to issue the Note and Warrant, and to enter into the security and pledge
agreement of even date herewith, in the form attached hereto as Exhibit C (the “Security and Pledge Agreement”),
and the other instruments, documents and agreements being entered in connection with the transactions contemplated by this Agreement
(each a “Subscription Document” and collectively, the “Subscription Documents”) and to carry
out and perform its obligations under the terms of the Subscription Documents. 

 

3.3             
Subsidiaries and Affiliates. Section 3.3 of the Disclosure
Schedule sets forth a true and correct description of all of the Company’s Subsidiaries and Affiliates and the capitalization
(including options, warrants and other such equity), pro forma as of the date hereof reflecting all pending acquisitions. For purposes
of this Agreement, the term “Subsidiary”
means, with
respect to the Company, any corporation
or other entity of
which at
least a
majority of
the outstanding
shares of
stock or
other ownership
interests having
by the
terms thereof
ordinary voting
power to
elect a
majority of
the board
of directors (or persons
performing similar
functions) of
such corporation
or entity (regardless
of whether or
not at
the time,
in the
case of a corporation,
stock of
any other
class or
classes of
such corporation
shall have
or might
have voting
power by
reason of
the happening
of any
contingency) is
at the time
directly or indirectly owned
or controlled by
the Company or one or
more of its Affiliates and the term “Affiliate”
means, as to
any person
(the “Subject
Person”),
any other
person that
directly or
indirectly through
one or
more intermediaries
controls or
is controlled
by, or
is under
direct or
indirect common control
with, the
Subject Person.
For the purposes
of this definition,
“control” when used
with respect to any
person means the power
to direct the
management and policies
of such person, directly
or indirectly, whether through
the ownership of
voting securities, through
representation on such
person’s board of
directors or other
management committee or group, by contract
or otherwise. All references contained herein to the terms Subsidiary or Affiliate,
shall be applicable to all Subsidiaries and Affiliates whether they existed as of the date hereof or were created, acquired, or
otherwise came to be included in the foregoing terms subsequent to the date hereof. 

 

3.4             
Authorization. All corporate action on the part of
the Company, its directors and its stockholders necessary for the authorization of the Subscription Documents and the execution,
delivery and performance of all obligations of the Company under the Subscription Documents, including, but not limited to, the
issuance and delivery of the Note and Warrant, and the reservation of the equity securities issuable upon conversion of the Note
and upon exercise of the Warrant (collectively, the “Underlying Securities”) has been taken or will be taken
prior to the issuance of such Underlying Securities. The Subscription Documents, when executed and delivered by the Company, shall
constitute valid and binding obligations of the Company enforceable in accordance with their terms, subject to laws of general
application relating to bankruptcy, insolvency, the relief of debtors and, with respect to rights to indemnity, subject to federal
and state securities laws. The Underlying Securities, when issued in compliance with the provisions of the Subscription Documents,
will be, validly issued, fully paid and non-assessable and free of any liens, encumbrances, security interests or other adverse
claim (a “Lien”) and issued in compliance with all applicable federal and securities laws.

 

    	3

    	 

    

 

3.5             
Governmental Consents. Neither Company nor any Subsidiary
is required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with,
any court or other foreign, federal, state, local or other governmental authority or other person in connection with the execution,
delivery and performance by the Company of the Subscription Documents, other than (a) applicable Blue Sky filings, (b) such as
have already been obtained or such exemptive filings as are required to be made under applicable securities laws, (c) such other
filings that have been made pursuant to applicable state securities laws and post-sale filings pursuant to applicable state and
federal securities laws which the Company undertakes to file within the applicable time periods. Subject to the accuracy of the
representations and warranties of the Purchaser set forth in Section 4 hereof, the Company has taken all action necessary to exempt:
(i) the issuance and sale of the Note and the Warrant, (ii) the issuance of the Underlying Securities upon due conversion of the
Note and due exercise of the Warrant, and (iii) the other transactions contemplated by the Subscription Documents from the provisions
of any preemptive rights, stockholder rights plan or other “poison pill” arrangement, any anti-takeover, business combination
or control share law or statute binding on the Company or to which the Company or any of its assets and properties may be subject
and any provision of the Company’s Articles of Incorporation or Bylaws, or other organizational documentation, as the case
may be, that is or could reasonably be expected to become applicable to the Purchaser as a result of the transactions contemplated
hereby, including without limitation, the issuance of the Note, the Warrant, and the Underlying Securities (collectively, the “Securities”)
and the ownership, disposition or voting of the Securities by the Purchaser or the exercise of any right granted to the Purchaser
pursuant to this Agreement or the other Subscription Documents.

 

3.6             
Compliance with Laws. Neither Company nor any Subsidiary
is in violation of any applicable statute, rule, regulation, order or restriction of any domestic or foreign government or any
instrumentality or agency thereof in respect of the conduct of its business or the ownership of its properties, which violation
would materially and adversely affect the business, assets, liabilities, financial condition or operations of Company and its Subsidiaries.

 

3.7             
Compliance with Other Instruments. Neither Company
nor any of its Subsidiaries is in violation or default of any term of its organizational documents, or of any provision of any
mortgage, indenture or contract to which it is a party and by which it is bound or of any judgment, decree, order or writ, other
than such violations that would not individually or in the aggregate have a Material Adverse Effect on the Company. Except as set
forth in Section 3.7 of the Disclosure Schedule, the execution, delivery and performance of the Subscription Documents, and the
consummation of the transactions contemplated by the Subscription Documents will not result in any such violation or be in conflict
with, or constitute, with or without the passage of time and giving of notice, either a default under any such provision, instrument,
judgment, decree, order or writ or an event that results in the creation of any Lien upon any assets of the Company or the suspension,
revocation, impairment, forfeiture, or nonrenewal of any material permit, license, authorization or approval applicable to the
Company or any of its Subsidiaries, its business or operations or any of its assets or properties. The sale of the Note, the issuance
of the Warrant and the subsequent issuance of the Underlying Securities are not and will not be subject to any preemptive rights
or rights of first refusal that have not been properly waived or complied with. 

 

    	4

    	 

    

 

3.8             
Offering. Assuming the accuracy of the representations
and warranties of the Purchaser contained in Section 4 hereof, the offer, issue, and sale of Securities are and will be exempt
from the registration and prospectus delivery requirements of the Securities Act, and have been registered or qualified or are
exempt from registration and qualification under the registration, permit, or qualification requirements of all applicable state
securities laws. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a
“Disqualification Event”) is applicable to the Company or, to the Company’s knowledge, any person listed
in the first paragraph of Rule 506(d)(1) of the Securities Act, except for a Disqualification Event as to which Rule 506(d)(2)(ii–iv)
or (d)(3), is applicable.

 

3.9             
Capitalization. Company has authorized shares as
set forth in Section 3.9 of the Disclosure Schedule. All outstanding shares of capital stock are duly authorized, validly issued,
fully paid and non-assessable and have been issued in compliance with all applicable securities laws. Except for the Warrant and
the Underlying Securities or as otherwise listed in Section 3.9 of the Disclosure Schedule, there are no outstanding options, warrants,
script rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any person any right to subscribe for or acquire, any shares of
common stock, or contracts, commitments, understandings or arrangements by which Company or any Subsidiary is or may become bound
to issue additional shares of common stock, or securities or rights convertible or exchangeable into shares of common stock. There
are no price based anti-dilution or price adjustment provisions contained in any security issued by Company (or in any agreement
providing rights to security holders) and the issue and sale of the Securities will not obligate Company to issue shares of common
stock or other securities to any person (other than the Purchaser) and will not result in a right of any holder of Company’s
securities to adjust the exercise, conversion, exchange or reset price under such securities. Except as set forth in Section 3.9
of the Disclosure Schedule, Company owns, directly or indirectly, all of the capital stock of each Subsidiary free and clear of
any Liens, and all the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid,
non-assessable and free of preemptive and similar rights. 

 

3.10         
SEC Reports; Financial Statements. Except as set
forth in Section 3.10 of the Disclosure Schedule, to the best of the Company’s knowledge the Company has filed all reports
and registration statements required to be filed by it under (i) the Securities Act and the Exchange Act of 1934, as amended (the
“Exchange Act”), including pursuant to Section 13(a) or 15(d) of the Exchange Act, or (ii) under the Alternative
Reporting Standard as offered by OTC Markets Group, for the two years preceding the date hereof (or such shorter period as the
Company was required by law to file such material) (the foregoing materials, including the exhibits thereto, being collectively
referred to herein as the “SEC Reports” and, together with the Disclosure Schedule to this Agreement, the “Disclosure
Materials”). As of their respective dates, to the best of the Company’s knowledge the SEC Reports complied in all
material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission
promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to
state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. Except as indicated in Section 3.10 of the Disclosure Schedule, to the best of the
Company’s knowledge the financial statements of the Company included in the SEC Reports comply in all material respects with
applicable accounting requirements and the rules and regulations of the Commission or OTC Markets as applicable, with respect thereto
as in effect at the time of filing. Such financial statements have been prepared in accordance with generally accepted accounting
principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified
in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes
required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of
unaudited statements, to normal, immaterial, year-end audit adjustments. 

 

    	5

    	 

    

 

3.11         
Material Changes. Since the date of the latest financial
statements, to the best of the Company’s knowledge (i) there has been no event, occurrence or development that, individually
or in the aggregate, has had or that could result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent
with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP
or required to be disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting or
the identity of its auditors, (iv) the Company has not declared or made any dividend or distribution of cash or other property
to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock, and (v)
the Company has not issued any equity securities to any officer, director or affiliate, except pursuant to existing Company stock-based
plans or agreements.

 

3.12         
Litigation. Except as set forth in Section 3.12 of
the Disclosure Schedule, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the
knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before
or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an “Action”) which: (i) adversely affects or challenges the legality, validity or enforceability
of any of the Subscription Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably
be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof,
is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by governmental authority, or any litigation civil or otherwise, involving the Company or any current or former
director or officer of the Company or its Subsidiaries. 

 

3.13         
Labor Relations. Neither Company nor any Subsidiary
is a party to or bound by any collective bargaining agreements or other agreements with labor organizations. Neither Company nor
any Subsidiary has violated in any material respect any laws, regulations, orders or contract terms, affecting the collective bargaining
rights of employees, labor organizations or any laws, regulations or orders affecting employment discrimination, equal opportunity
employment, or employees’ health, safety, welfare, wages and hours. No material labor dispute exists or, to the knowledge
of the Company, is imminent with respect to any of the employees of the Company which could reasonably be expected to result in
a Material Adverse Effect. 

 

    	6

    	 

    

 

3.14         
Regulatory Permits. Company and the Subsidiaries
possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities
necessary to conduct their respective businesses, except where the failure to possess such permits would not have or reasonably
be expected to result in a Material Adverse Effect (“Material Permits”), and neither Company nor any Subsidiary
has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

3.15         
Title to Assets. Except as set forth in Section 3.15
of the Disclosure Schedule, Company and the Subsidiaries have good and marketable title in fee simple to all real property owned
by them that is material to the business of Company and the Subsidiaries and good and marketable title in all personal property
owned by them that is material to the business of Company and the Subsidiaries, in each case free and clear of all Liens, except
for Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed
to be made of such property by Company and the Subsidiaries and Liens for the payment of federal, state or other taxes, the payment
of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases of which Company and the Subsidiaries are in compliance.

 

3.16         
Taxes. Except as otherwise itemized in Section 3.16
of the Disclosure Schedule, Company and its Subsidiaries have timely and properly filed all tax returns required to be filed by
them for all years and periods (and portions thereof) for which any such tax returns were due, except where the failure to so file
would not have a Material Adverse Effect; all such filed tax returns are accurate in all material respects; the Company has timely
paid all taxes due and payable (whether or not shown on filed tax returns), except where the failure to so pay would not have a
Material Adverse Effect; there are no pending assessments, asserted deficiencies or claims for additional taxes that have not been
paid; the reserves for taxes, if any, reflected in the financial statements are adequate, and there are no Liens for taxes on any
property or assets of the Company and any of its Subsidiaries (other than Liens for taxes not yet due and payable); there have
been no audits or examinations of any tax returns by any (a) nation, state, commonwealth, province, territory, county, municipality,
district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; or (c) governmental
or quasi-governmental authority of any nature (including any governmental or administrative division, department, agency, commission,
instrumentality, official, organization, unit, body or entity) and any court or other tribunal (a “Governmental Body”),
and the Company or its Subsidiaries have not received any notice that such audit or examination is pending or contemplated; no
claim has been made by any Governmental Body in a jurisdiction where the Company or any of its Subsidiaries does not file tax returns
that it is or may be subject to taxation by that jurisdiction; to the knowledge of the Company, no state of facts exists or has
existed which would constitute grounds for the assessment of any penalty or any further tax liability beyond that shown on the
respective tax returns; and there are no outstanding agreements or waivers extending the statutory period of limitation for the
assessment or collection of any tax. 

 

    	7

    	 

    

 

3.17         
Patents and Trademarks. Company and the Subsidiaries
have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names,
copyrights, licenses and other similar rights that are necessary or material for use in connection with their respective businesses
and which the failure to so have could have or reasonably be expected to result in a Material Adverse Effect (collectively, the
“Intellectual Property Rights”). Neither Company nor any Subsidiary has received a written notice that the Intellectual
Property Rights used by Company or any Subsidiary violates or infringes upon the rights of any Person. All such Intellectual Property
Rights are enforceable. Company and its Subsidiaries have taken reasonable steps to protect Company’s and its Subsidiaries’
rights in their Intellectual Property Rights and confidential information (the “Confidential Information”).
Each employee, consultant and contractor who has had access to Confidential Information which is necessary for the conduct of Company’s
and each of its Subsidiaries’ respective businesses as currently conducted or as currently proposed to be conducted has executed
an agreement to maintain the confidentiality of such Confidential Information and has executed appropriate agreements that are
substantially consistent with the Company’s standard forms thereof. Except under confidentiality obligations, there has been
no material disclosure of any of Company’s or its Subsidiaries’ Confidential Information to any third party.

 

3.18         
Environmental Matters. Neither Company nor any Subsidiary
is in violation of any statute, rule, regulation, decision or order of any Governmental Body relating to the use, disposal or release
of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous
or toxic substances (collectively, “Environmental Laws”), owns or operates any real property contaminated with
any substance that is subject to any Environmental Laws, is liable for any off-site disposal or contamination pursuant to any Environmental
Laws, or is subject to any claim relating to any Environmental Laws, which violation, contamination, liability or claim has had
or could reasonably be expected to have a Material Adverse Effect, individually or in the aggregate; and there is no pending or,
to the Company’s knowledge, threatened investigation that might lead to such a claim.

 

3.19         
Insurance. Inventory shall be kept in a bonded warehouse
and the Company will not sell merchandise into the marketplace without first obtaining liability insurance.

 

3.20         
Transactions with Affiliates and Employees. Except
as disclosed in the Company’s audited financial statements or the Disclosure Materials, none of the officers or directors
of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction
with Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or
from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner,
other than (a) for payment of salary or consulting fees for services rendered, (b) reimbursement for expenses incurred on behalf
of the Company and (c) for other employee benefits, including stock option agreements under any stock option plan of Company. 

 

3.21         
Brokers and Finders. Except as otherwise itemized
in Section 3.21 of the Disclosure Schedule, no person will have, as a result of the transactions contemplated by the Subscription
Documents, any valid right, interest or claim against or upon Company, any Subsidiary or the Purchaser for any commission, fee
or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company. 

 

    	8

    	 

    

 

3.22         
Questionable Payments. Neither Company nor
any of its Subsidiaries nor, to the Company’s knowledge, any of their respective current or former stockholders, directors,
officers, employees, agents or other persons acting on behalf of Company or any Subsidiary, has on behalf of Company or any Subsidiary
or in connection with their respective businesses: (a) used any corporate funds for unlawful contributions, gifts, entertainment
or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful payments to any governmental
officials or employees from corporate funds; (c) established or maintained any unlawful or unrecorded fund of corporate monies
or other assets; (d) made any false or fictitious entries on the books and records of Company or any Subsidiary; or (e) made any
unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature.

 

3.23         
Solvency. The Company has not (a) made a general
assignment for the benefit of creditors; (b) filed any voluntary petition in bankruptcy or suffered the filing of any involuntary
petition by its creditors; (c) suffered the appointment of a receiver to take possession of all, or substantially all, of its assets;
(d) suffered the attachment or other judicial seizure of all, or substantially all, of its assets; (e) admitted in writing its
inability to pay its debts as they come due; or (f) made an offer of settlement, extension or composition to its creditors generally.

 

3.24         
Foreign Corrupt Practices Act. None of Company or
any of its Subsidiaries, nor to the knowledge of the Company, any agent or other person acting on behalf of the Company or any
of its Subsidiaries, has, directly or indirectly: (a) used any funds, or will use any proceeds from the sale of the Securities,
for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity,
(b) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (c) failed to disclose fully any contribution made by Company or any of its Subsidiaries
(or made by any person acting on their behalf of which the Company is aware) or any members of their respective management which
is in violation of any legal requirement, or (d) has violated in any material respect any provision of the Foreign Corrupt Practices
Act of 1977, as amended, and the rules and regulations thereunder which was applicable to Company or any of its Subsidiaries.

 

3.25         
Disclosures. Neither the Company nor any person acting
on its behalf has provided the Purchaser or its agents or counsel with any information that constitutes or might constitute material,
non-public information, other than the terms of the transactions contemplated hereby. The written materials delivered to the Purchaser
in connection with the transactions contemplated by the Subscription Documents do not contain any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements contained therein, in light of the circumstances
under which they were made, not misleading.

 

3.26         
Transfer Agent. Company represents and warrants that
it will not replace its transfer agents without Purchaser’s consent so long as the Note is outstanding. Company acknowledges
that this is extremely material to the Note and the investment is made based on the assumption that this will not happen.

 

    	9

    	 

    

 

3.27         
Shell Company Status. Set forth in Schedule 3.27
of the Disclosure Schedule is the Company’s representation as to its “Shell Company” status under Rule 144.

 

3.28         
Notice of Material Changes. The Company agrees and
acknowledges that so long as any obligations of the Company under any of the Subscription Documents shall exist, it shall be obligated
to provide Notice to the Purchaser in the event of a material change to any representation or disclosure in any of the Subscription
Documents, including but not limited to, the disclosures on the Disclosure Schedule, and failure to provide such notice shall be
a breach of this Agreement and an Event of Default under Section 4.3 of the Note.

 

	4.	Representations and Warranties of the
Purchaser

 

4.1             
Purchase for Own Account. The Purchaser represents
that it is acquiring the Note for its own account. 

 

4.2             
Information and Sophistication. Without lessening
or obviating the representations and warranties of the Company set forth in Section , the Purchaser hereby: (a) acknowledges that
it has received all the information it has requested from the Company and it considers necessary or appropriate for deciding whether
to acquire the Note, (b) represents that it has had an opportunity to ask questions and receive answers from the Company regarding
the terms and conditions of the offering of the Note and to obtain any additional information necessary to verify the accuracy
of the information given the Purchaser and (c) further represents that it has such knowledge and experience in financial and business
matters that it is capable of evaluating the merits and risk of this investment.

 

4.3             
Ability to Bear Economic Risk. The Purchaser acknowledges
that investment in the Note involves a high degree of risk, and represents that it is able, without materially impairing its financial
condition, to hold the Note for an indefinite period of time and to suffer a complete loss of its investment.

 

4.4             
Accredited Investor Status. The Purchaser is an “accredited
investor” as such term is defined in Rule 501 under the Act.

 

4.5             
Existence; Authorization. The Purchaser is a limited
liability company duly organized, validly existing and in good standing under the laws of the state of its organization, having
full power and authority to own its properties and to carry on its business as conducted. The principal place of business of the
Purchaser is as shown on the signature block below. The Purchaser has the requisite power and authority to deliver this Agreement,
perform its obligations set forth herein, and consummate the transactions contemplated hereby. The Purchaser has duly executed
and delivered this Agreement and has obtained the necessary authorization to execute and deliver this Agreement and to perform
his, her or its obligations herein and to consummate the transactions contemplated hereby. This Agreement, assuming the due execution
and delivery hereof by the Company, is a legal, valid and binding obligation of the Purchaser enforceable against the Purchaser
in accordance with its terms.

 

4.6             
No Regulatory Approval. The Purchaser understands
that no state or federal authority has scrutinized this Agreement or the Note offered pursuant hereto, has made any finding or
determination relating to the fairness for investment in the Note, or has recommended or endorsed the Note, and that the Note has
not been registered or qualified under the Act or any state securities laws, in reliance upon exemptions from registration thereunder.
The Note may not, in whole or in part, be resold, transferred, assigned or otherwise disposed of unless it is registered under
the Act or an exemption from registration is available, and unless the proposed disposition is in compliance with the restrictions
on transferability under federal and state securities laws.

 

    	10

    	 

    

 

4.7             
Purchaser Received Independent Advice. The Purchaser
confirms that the Purchaser has been advised to consult with the Purchaser’s independent attorney regarding legal matters
concerning the Company and to consult with independent tax advisers regarding the tax consequences of investing in the Company.
The Purchaser acknowledges that Purchaser understands that any anticipated United States federal or state income tax benefits may
not be available and, further, may be adversely affected through adoption of new laws or regulations or amendments to existing
laws or regulations. The Purchaser acknowledges and agrees that the Company is providing no warranty or assurance regarding the
ultimate availability of any tax benefits to the Purchaser by reason of the subscription.

 

4.8             
Legends. The Purchaser understands that until such
time as the Securities have been registered under the Securities Act or may be sold pursuant to Rule 144, Rule 144A under the Securities
Act or Regulation S without any restriction as to the number of securities as of a particular date that can then be immediately
sold, the Underlying Securities shall bear a restrictive legend in substantially the following form (and a stop-transfer order
may be placed against transfer of the certificates for such securities):

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE
OR EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES
MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE
SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
SECURED BY THE SECURITIES.”

 

	5.	Further Agreements; Post-Closing Covenants

 

5.1             
Intentionally Omitted.

 

    	11

    	 

    

 

5.2             
Intentionally Omitted. 

 

5.3             
Use of Proceeds. Company agrees to use the
Consideration to be paid by Purchaser to the Company for general working capital purposes.

 

5.4             
Form D; Blue Sky Laws. Company agrees to file a Form
D with respect to the Securities as required under Regulation D and to provide a copy thereof to the Purchaser promptly after such
filing. Company shall take such action as Company shall reasonably determine is necessary to qualify the Securities for sale to
the Purchaser at the applicable Closing pursuant to this Agreement under applicable securities or “blue sky” laws of
the states of the United States (or to obtain an exemption from such qualification), and
shall provide evidence
of any such
action so taken
to the Purchaser
on or prior
to the initial Closing.

 

5.5             
Usury. To the extent it may lawfully do so, the Company
hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled
to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any
action or proceeding that may be brought by the Purchaser in order to enforce any right or remedy under the Note. Notwithstanding
any provision to the contrary contained in the Note, it is expressly agreed and provided that the total liability of the Company
under the Note for payments which under Delaware law are in the nature of interest shall not exceed the maximum lawful rate authorized
under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of
interest or default interest, or both of them, when aggregated with any other sums which under Delaware law in the nature of interest
that the Company may be obligated to pay under the Note exceed such Maximum Rate. It is agreed that if the maximum contract rate
of interest allowed by Delaware law and applicable to the Note is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable
to the Note from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances
whatsoever, interest in excess of the Maximum Rate is paid by the Company to the Purchaser with respect to indebtedness evidenced
by the Note, such excess shall be applied by the Purchaser to the unpaid principal balance of any such indebtedness or be refunded
to the Company, the manner of handling such excess to be at the Purchaser’s election.

 

5.6             
Registration Rights. 

 

(a)               
Company shall give the Purchaser prompt written notice of each filing by Company
with the SEC, of a registration statement (other than a registration statement on Form S-4 or Form S-8 or on any successor forms
thereto), or an offering statement under Regulation A promulgated
under the Act (in each case, referred to hereinafter as a “Registration”). If requested by the Purchaser in
writing within three (3) days after receipt of any such notice, Company shall, at Company’s sole expense (other than the
underwriting discounts, if any, payable in respect of the shares sold by the Purchaser), register or otherwise include all or,
at Purchaser’s option, any portion of the Securities, concurrently with the registration of such other securities, all to
the extent requisite to permit the public offering and sale of the Securities through the securities exchange, if any, on which
the shares of common stock is being sold or on the over-the-counter market.

 

    	12

    	 

    

 

(b)              
In the event of a Registration pursuant to the provisions of this section, Company
shall furnish to the Purchaser such reasonable number of copies of the registration statement or offering statement and of each
amendment and supplement thereto (in each case, including all exhibits), of each prospectus contained in such registration statement
or offering statement and each supplement or amendment thereto (including each preliminary prospectus), and such other documents,
as the Purchaser may reasonably request to facilitate the disposition of the Securities included in such registration.

 

(c)               
Company shall notify the Purchaser within five (5) business days after such
registration statement or offering statement has become effective or qualified, or a supplement to any prospectus forming a part
of such registration statement or offering statement has been filed.

 

(d)              
Any references herein to (A) a registration statement shall be deemed to also
be references to a Form 1-A Regulation A Offering Statement, (B) prospectus shall be deemed to also be references to offering circular,
and (C) effective date of a registration statement shall be deemed to also be references to qualification date of an offering statement.
The Purchaser’s rights under this Section 5.6 shall automatically terminate once the Purchaser has sold all of the Underlying
Securities.

 

5.7             
Legal Counsel Opinions. 

 

(a)               
Upon the request of the Purchaser from to time to time, Company shall be responsible (at Company’s
cost) for promptly supplying to Company’s transfer agent and the Purchaser a customary legal opinion letter (the “Legal
Counsel Opinion”) to the effect that the resale of the Underlying Securities by the Purchaser or its affiliates, successors
and assigns is exempt from the registration requirements of the 1933 Act pursuant to Rule 144 (provided the requirements of Rule
144 are satisfied and provided the Underlying Securities are not then registered under the 1933 Act for resale pursuant to an effective
registration statement). Should Company fail for any reason to obtain and cause to be issued the Legal Counsel Opinion, the Purchaser
may (at Company’s cost, or if paid by Purchaser, then with costs added to the conversion amount) secure another legal counsel
to issue the Legal Counsel Opinion, and Company will instruct its transfer agent to accept such opinion. Company shall not impede
the removal by its stock transfer agent of the restricted legend from any common stock certificate upon receipt by the transfer
agent of a Rule 144 Opinion Letter. COMPANY HEREBY AGREES THAT IT MAY NEVER TAKE THE POSITION THAT IT IS A “SHELL COMPANY”
IN CONNECTION WITH ITS OBLIGATIONS UNDER THIS AGREEMENT.

 

5.8             
Listing. Company will, so long as the Purchaser owns
any of the Securities, maintain the listing and trading of its Common Shares on OTC Markets or any equivalent trading platform
or electronic quotation system and will comply in all respects with Company’s reporting, filing and other obligations under
the bylaws or rules of the Financial Industry Regulatory Authority, or FINRA, and such exchanges, as applicable, as well as with
the SEC. Company shall promptly provide to the Purchaser copies of any notices it receives from OTC Markets and any other exchanges
or electronic quotation systems on which the Common Shares are then traded regarding the continued eligibility of the Common Shares
for listing on such trading platforms and quotation systems.

 

    	13

    	 

    

 

5.9             
Information and Observer Rights. As long as the Purchaser
owns at least five percent (5%) of the Securities originally purchased hereunder, Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by Company pursuant to the Exchange
Act. As long as the Purchaser owns at least five percent (5%) of the Securities originally purchased hereunder, if Company is not
required to file reports pursuant to such laws, it will prepare and furnish to the Purchaser and simultaneously make publicly available
in accordance with Rule 144(c) such information as is required for the Purchaser to sell the Securities under Rule 144. Company
further covenants that it will take such further action as any holder of Securities may reasonably request, all to the extent required
from time to time to enable the Purchaser to sell the Securities without registration under the Securities Act within the limitation
of the exemptions provided by Rule 144. If Company fails to remain current in its reporting obligations or to provide currently
publicly available information in accordance with Rule 144(c) and such failure extends for a period of more than 30 Trading Days
(the date which such 30 Trading Day-period is exceeded, being referred to as “Event Date”), then in addition
to any other rights the Purchaser may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary
of each such Event Date (if the applicable Event shall not have been cured by such date) until the information failure is cured,
Company shall pay to the Purchaser an amount in cash, as partial liquidated damages and not as a penalty, equal to one percent
(1%) of purchase price paid for the Securities held by the Purchaser at the Event Date. The partial liquidated damages pursuant
to the terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the cure of an information failure
(except in the case of the first Event Date).

 

5.10         
Confidentiality. The Purchaser agrees that the it
will keep confidential and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company)
the terms and conditions of this Agreement or any confidential information obtained from the Company pursuant to the terms of this
Agreement (including notice of Company’s intention to file a registration statement), unless such confidential information
(a) is known or becomes known to the public in general (other than as a result of a breach of this Section 5.10 by the Purchaser),
(b) is or has been independently developed or conceived by the Purchaser without use of the Company’s confidential information,
or (c) is or has been made known or disclosed to the Purchaser by a third party without a breach of any obligation of confidentiality
such third party may have to the Company; provided, however, that the Purchaser may disclose confidential information (i) to its
attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with
monitoring its investment in the Company; (ii) to any prospective purchaser of any Securities from the Purchaser, if such prospective
purchaser agrees to be bound by the provisions of this Section 5.10; (iii) to any existing or prospective
affiliate, partner, member, stockholder, or wholly owned subsidiary of the Purchaser in the ordinary course of business, provided
that the Purchaser informs such person that such information is confidential and directs such person to maintain the confidentiality
of such information; or (iv) as may otherwise be required by law, provided that the Purchaser notifies the Company within
three (3) business days of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure.

 

    	14

    	 

    

 

5.11         
Restrictions on Activities. Commencing as of the
date first above written, and so long as the Company has an obligation under the Note, the Company shall not, directly or indirectly,
without the Purchaser’s prior written consent, which consent shall not
be unreasonably withheld:
(a) change the
nature of its
business; (b) sell,
divest, acquire, change
the structure of any material assets other than in the ordinary course of business; (c) solicit any offers for, respond
to any unsolicited offers for, or conduct any negotiations with any other person or entity in respect of any variable rate debt
transactions (i.e., transactions were the conversion or exercise price of the security issued by the Company varies based on the
market price of the Common Shares); or (d) accept Merchant-Cash-Advances.

 

5.12         
Other Restrictions. Unless approved by the Purchaser,
Company and each Subsidiary shall not enter into an agreement or amend an existing agreement
to effect any sale of securities involving, or convert any securities previously issued under, a Variable Rate Transaction or a
merchant cash advance transaction in which it sells future receivables at a discount, or a substantially similar transaction. The
term “Variable Rate Transaction” means a transaction in which Company or any Subsidiary (i) issues or sells
any convertible securities either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies
with the trading prices of, or quotations for, the Common Shares at any time after
the initial issuance of such convertible securities, or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such convertible securities or upon the occurrence of specified or contingent
events directly or indirectly related to the business of Company or the Subsidiary, as the case may be, or the market for the Common
Shares, other than pursuant to a customary “weighted average” anti-dilution provisions, or (ii) enters into any agreement
(including, without limitation, an “equity line of credit” or an “at-the-market offering”) whereby Company
or any Subsidiary may sell securities at a future determined price (other than standard and customary “preemptive”
or “participation” rights). The Purchaser shall be entitled to obtain injunctive relief against Company and its
Subsidiaries to preclude any such issuance, which remedy shall be in addition to any right to collect damages.

 

5.13         
Sale of Assets; Issuance of Equity or Debt. Subject
to the following provisions, should Company sell any material assets, or issue any equity, debt, or other security, including the
sale of any Subsidiary, that generate cash proceeds to the Company, the Purchaser shall have the right to be repaid on any outstanding
amount owed under the Note with up to 100% of the proceeds of any such sale or offering, provided, however, that this provision
is not applicable to (i) the first $2,000,000 of cash proceeds in the aggregate, generated in such transactions, (ii) asset-based
loans or lines of credit obtained by the Company, or (iii) transactions generating future financing proceeds with a specific use
of proceeds requirement that such proceeds are to be used exclusively to purchase the assets or equity of an unaffiliated business
in an arm’s length acquisition and the proceeds are used accordingly.

 

5.14         
Participation Rights. For a period of eighteen (18)
months from the Initial Closing Date, in the event Company or any Subsidiary proposes to offer and sell its securities, whether
in the form of debt, Equity Financing (defined below), or any other financing transaction (each a “Future Offering”),
the Purchaser shall have the right, but not the obligation, to participate in the purchase of the securities being offered up to
an amount equal to the Consideration in strict accordance with the terms of such Future Offering (the “Participation Right”).
For the avoidance of doubt, an “Equity Financing” shall mean Company’s or its Subsidiary’s sale of its
Common Shares or any securities conferring the right to purchase Company’s or Subsidiary’s common stock or securities
convertible into, or exchangeable for (with or without additional consideration), shares of the Company’s or Subsidiary’s
common stock. In connection with each Participation Right, Company shall provide written
notice to the Purchaser of the terms and conditions of the Future Offering at least 10 business days prior to the anticipated first
closing of such Future Financing (the “FF Notice”). If the Purchaser shall elect to exercise its Participation
Right, it shall notify Company, in writing, of such election at least five (5) business days prior to the anticipated closing date
set forth in the FF Notice (the “Participation Notice”). In the event the Purchaser does not return a Participation
Notice to Company within such five (5) business day period, the Participation Right granted hereunder shall terminate and be of
no further force and effect; provided, however, that such Participation Right shall be reinstated if the anticipated closing referenced
in the FF Notice does not occur prior to 10 business days following the anticipated first closing date specified in such FF notice.

 

    	15

    	 

    

 

5.15         
Right of First Refusal. If at any time while this
Note is outstanding, the Company or any Subsidiary has a bona fide offer of capital or financing from any third party that the
Company or Subsidiary intends to act upon, then the Company must first offer such opportunity to the Purchaser to provide such
capital or financing to the Company or Subsidiary on the same terms as each respective third party’s terms. Should the Purchaser
be unwilling or unable to provide such capital or financing to the Company within 10 Trading Days from Purchaser’s receipt
of written notice of the offer (the “Offer Notice”) from the Company, then the Company or Subsidiary may obtain
such capital or financing from that respective third party. If the Company does not receive the capital or financing from the respective
third party within 60 days after the date of the respective Offer Notice, then the Company must again offer the capital or financing
opportunity to the Purchaser as described above, and the process detailed above shall be repeated. The Offer Notice must be sent
via electronic mail to avi@leonitecap.com Cc: dberger@bergerlawpllc.com.

 

5.16         
Terms of Future Financings. So long as any obligations
of the Company under the Subscription Documents are outstanding, solely in connection with a financing of the Company and subject
to the provisions of this section, upon any issuance of (or announcement of intent to effect an issuance of) any security, or amendment
to (or announcement of intent to effect an amendment to) any security that was originally issued before the Issue Date, by the
Company or any Subsidiary, with any term that in the aggregate with all of the terms in such future financing, is more favorable
to the holder of such security than, or with a term in favor of the holder of such security that was not similarly provided to,
the Purchaser in the Subscription Documents, then (i) the Company shall notify the Purchaser of such additional or more favorable
term within five (5) business days of the new issuance and/or amendment (as applicable) of the respective security, and (ii) such
term, at Purchaser’s option, shall become a part of the transaction documents with the Purchaser (regardless of whether the
Company complied with the notification provision of this Section 5.16), provided, however, that this provision is not applicable
to (i) the Company’s Form 1-A Regulation A Offering Statement which qualified with the SEC on November 1, 2021, (ii) compensation
paid by the Company to Costaldo Law Group P. C. or its assigns, or Grace Court Advisors Inc. or its assigns, (iii) compensation
paid by the Company to its employees or directors, or (iv) compensation paid by the Company to consultants, service providers,
advisors, or vendors in Common Shares or securities of the Company at market value as of the date of issuance. The types of terms
contained in another security that may be more favorable to the purchaser of such security include, but are not limited to, terms
addressing conversion discounts, prepayment rate, conversion lookback periods, interest rates, original issue discounts, commitment
shares, stock sale price, private placement price per share, and warrant coverage. If Purchaser
elects to have the term become a part of the transaction documents with the Purchaser, then the Company shall immediately deliver
acknowledgment of such adjustment in form and substance reasonably satisfactory to the Purchaser (the “Acknowledgment”)
within 30 days of Company’s receipt of request from Purchaser (the “Adjustment Deadline”), provided that Company’s
failure to timely provide the Acknowledgement shall not affect the automatic amendments contemplated hereby.

 

    	16

    	 

    

 

5.17         
Breach of Covenants. The Company acknowledges and
agrees that if the Company breaches any covenants set forth in this Section, in addition to any other remedies available to the
Purchaser pursuant to this Agreement, it will be considered an Event of Default under Section 4.3 of the
Note.

 

5.18         
Transfer Agent
Instructions.
Company shall issue irrevocable
instructions to Company’s transfer
agent to issue
certificates, registered in
the name of
the Purchaser or
its nominee, upon
exercise of the Warrant, in such amounts as specified from time to time by the Purchaser to Company in accordance with the
terms thereof (the “Irrevocable Transfer Agent Instructions”). In the event that Company proposes to replace
its transfer agent, Company shall provide, prior to the effective date of such replacement, a fully executed Irrevocable
Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement (including but not limited to the provision
to irrevocably reserved Common Shares in the Reserved Amount (as defined in the Note)) signed by the successor transfer agent to
Company and Company. Prior to registration of the Underlying Securities under the Securities Act or the date on which the Underlying
Securities may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that
can then be immediately sold, all such certificates shall bear the restrictive legend specified in Section 4.8 of this Agreement.
Company warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5.18
will be given by Company to its transfer agent; (ii) it will not direct its transfer agent not to transfer or delay, impair, and/or
hinder its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for Underlying
Securities to be issued to the Purchaser upon conversion of or otherwise pursuant to the Note as and when required by the Note
and this Agreement; (iii) it will not fail to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders
its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on
any certificate for any Underlying Securities issued to the Purchaser upon conversion of or otherwise pursuant to the Note as and
when required by the Note and this Agreement, and (iv) it will provide any required corporate resolutions and issuance approvals
to its transfer agent if and as required by its transfer agent. Nothing in this Section shall affect in any way the Purchaser’s
obligations and agreement set forth in Section 5.6 hereof to comply with all applicable prospectus delivery requirements, if any,
upon re-sale of the Underlying Securities. If the Purchaser provides Company with an opinion of counsel in form, substance and
scope customary for opinions in comparable transactions, to the effect that a public sale or transfer of such Securities may be
made without registration under the 1933 Act pursuant to Rule 144, or other exemptions, and such sale or transfer is effected through
an opinion of counsel, the Company shall permit the transfer, and, in the case of the Underlying Securities, promptly instruct
its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as specified
by the Purchaser. Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Purchaser,
by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, Company acknowledges that the remedy
at law for a breach of its obligations under this Section 5.18 may be inadequate and agrees, in the event of a breach or threatened
breach by Company of the provisions of this Section, that the Purchaser shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without
any bond or other security being required.

 

    	17

    	 

    

 

5.19         
Further Assurances. The Purchaser agrees and covenants
that at any time and from time to time it will execute and deliver to the Company such further instruments and documents and take
such further action as the Company may reasonably require within three (3) business days of any such request in order to carry
out the full intent and purpose of this Agreement and to comply with state or federal securities laws
or other regulatory approvals.

 

5.20         
Exchange Act Reporting.
Failure to remain subject to and fully compliant with the SEC reporting requirements under
the Exchange Act (including but not limited to becoming delinquent in its filings) for 30 consecutive days, shall be an event of
default under the Note and this Agreement until such time that such delinquency has been cured.

 

	6.	Conditions to the Company’s Obligation
to Sell

 

The obligation of the Company
hereunder to issue and sell the Note to the Purchaser, on the Initial Closing Date, is subject to the satisfaction, at or before
the Initial Closing Date, of each of the following conditions thereto, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion:

 

(a)               
The Purchaser shall have executed this Agreement and delivered the same to the
Company.

 

(b)              
The Purchaser
shall have delivered
the Initial Tranche in
accordance with Sections 1.1, 1.3
and 2.2(a) above.

 

(c)               
The representations and warranties of the Purchaser shall be true and correct in all material
respects as of the date when made and as of the Initial Closing Date, as though made at that time (except for representations and
warranties that speak as of a specific date), and the Purchaser shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Purchaser
at or prior to the Initial Closing Date.

 

(d)              
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any
self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the
transactions contemplated by this Agreement.

 

    	18

    	 

    

 

	7.	Conditions to The Purchaser’s
Obligation to Purchase

 

The obligation of the Purchaser
hereunder to purchase the Note from the Company, on the Initial Closing Date, is subject to the satisfaction, at or before the
Initial Closing Date, of each of the following conditions, provided that these conditions are for the Purchaser’s sole benefit
and may be waived by the Purchaser at any time in its sole discretion:

 

(a)               
The Company shall have executed this Agreement and delivered the same to the
Purchaser.

 

(b)              
The Company shall have delivered to the Purchaser the duly executed Note.

 

(c)               
Intentionally Omitted.

 

(d)              
Company shall have delivered executed Subscription Documents, with the exception of the Warrant
which shall be delivered on the Final Closing Date, or such other instruments as contemplated by this Agreement.

 

(e)               
Intentionally Omitted.

 

(f)               
The Company has provided the Purchaser with a current schedule of liabilities.

 

(g)              
Intentionally Omitted.

 

(h)              
The representations and warranties of the Company shall be true and correct in all material
respects as of the date when made and as of the Initial Closing Date, as though made at such time (except for representations and
warranties that speak as of a specific date) and the Company shall have performed, satisfied and complied in all material respects
with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company
at or prior to the Initial Closing Date.

 

(i)                
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any
self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the
transactions contemplated by this Agreement.

 

(j)                
No event shall have occurred which could reasonably be expected to have a Material Adverse
Effect on the Company including but not limited to a change in the Exchange Act reporting status of the Company or the failure
of the Company to be timely in its Exchange Act reporting obligations. 

 

(k)              
Company shall have delivered to the Purchaser (i) a certificate evidencing the formation and
good standing of Company in its jurisdiction of formation issued by the Secretary of State (or comparable office) of such jurisdiction,
as of a date within ten (10) days of the Initial Closing Date; and (ii) resolutions adopted by the Company’s Board of Directors
at a duly called meeting or by unanimous written consent authorizing this Agreement and all other documents, instruments and transactions
contemplated hereby. 

 

    	19

    	 

    

 

(l)                
Intentionally Omitted. 

 

(m)            
Intentionally Omitted. 

 

	8.	Miscellaneous

 

8.1             
Binding Agreement. The terms and conditions
of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties. Nothing
in this Agreement, expressed or implied, is intended to confer upon any third party any rights, remedies, obligations, or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement.

 

8.2             
Governing Law; Consent to Jurisdiction. This Agreement
shall be governed by and construed under the laws of the State of Delaware, without giving effect to conflicts of laws principles.
Each party to this Agreement hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting
in Delaware, for the adjudication of any dispute hereunder or in connection with any transaction contemplated hereby, and hereby
irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy thereof (certified or registered mail, return receipt
requested) to such party at the address in effect for notices to it under this agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. 

 

8.3             
Counterparts. This Agreement may be executed in two
(2) or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for
all purposes.

 

8.4             
Titles and Subtitles. The titles and subtitles used
in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

8.5             
Notices. All notices required or permitted hereunder
shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when
sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient, if not, then on the next
business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid,
or (d) one day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification
of receipt. All communications shall be sent to the Company and to the Purchaser at the addresses set forth on the signature page
to this Agreement or at such other addresses as the Company or Purchaser may designate by 10 days’ advance written notice
to the other parties hereto.

 

8.6             
Modification; Waiver. No modification or waiver of
any provision of this Agreement or consent to departure therefrom shall be effective only upon the written consent of the Company
and the Purchaser. Any provision of the Note may be amended or waived by the written consent of the Company and the Purchaser.

 

    	20

    	 

    

 

8.7             
Expenses. The Company and the Purchaser shall each
bear its respective expenses and legal fees incurred with respect to this Agreement and the transactions contemplated herein.

 

8.8             
Delays or Omissions. It is agreed that no delay or
omission to exercise any right, power or remedy accruing to the Purchaser, upon any breach or default of the Company under the
Subscription Documents shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach
or default, or any acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of
any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. It is further
agreed that any waiver, permit, consent or approval of any kind or character by Purchaser of any breach or default under this Agreement,
or any waiver by any Purchaser of any provisions or conditions of this Agreement must be in writing and shall be effective only
to the extent specifically set forth in writing and that all remedies, either under this Agreement, or by law or otherwise afforded
to the Purchaser, shall be cumulative and not alternative.

 

8.9             
Entire Agreement. This Agreement and the Exhibits
hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof and no
party shall be liable or bound to any other party in any manner by any representations, warranties, covenants and agreements except
as specifically set forth herein.

 

[Signature page
follows]

 

 

    	21

    	 

    

 

In
Witness Whereof, the parties have executed this Securities Purchase Agreement
as of the date first written above.

 

	COMPANY:	 
	 	 
	SENTIENT
BRANDS HOLDINGS INC.	 
	By:
	/s/
George Furlan	 
	Name:
George Furlan	 
	Title:
Interim Chief Executive Officer	 

 

	Address:	555
Madison Avenue, 5th Floor
	 	New York, New
York 10022
	 	 
	PURCHASER:
	 	 
	LEONITE
FUND I, LP
	By
its Manager, Leonite Advisors LLC

 

	By:
	/s/
Avi Geller	 
	Name:
Avi Geller	 
	Title:
Manager	 

 

	Address:	1
Hillcrest Center Dr., Suite 232
	 	Spring Valley,
NY 110977

 

[Securities Purchase Agreement – Signature
page]

 

    	22

    	 

    

 

SCHEDULE I 

Disclosure Schedule

 

Section 3.3 Subsidiaries and Affiliates

 

Section 3.7 Compliance with Other Instruments

 

Section 3.9 Capitalization

 

Section 3.10 SEC Reports; Financial Statements

 

Section 3.12 Litigation

 

Section 3.15 Title to Assets

 

Section 3.16 Taxes

 

Section 3.21 Brokers and Finders

 

Section 3.27 Shell Company Status 

 

Section 7(f) Schedule of Liabilities 

 

    	 

    	 

    

 

Exhibit
A

 

Form
of Convertible Promissory Note

 

(See
Attached)

 

    	 

    	 

    

 

Exhibit
B

 

Form
of Warrant

 

(See
Attached)

 

    	 

    	 

    

 

Exhibit
C

 

Form
of Security and Pledge Agreement

 

(See
Attached)Exhibit 4.14

 

THE ISSUER WILL MAKE AVAILABLE TO ANY
HOLDER OF THIS NOTE: (1) THE ISSUE PRICE AND ISSUE DATE OF THE NOTE, (2) THE MATURITY DATE OF THE NOTE, AND (3) ANY OTHER INFORMATION
REQUIRED TO BE MADE AVAILABLE BY U.S. TREASURY REGULATIONS UPON RECEIVING A WRITTEN REQUEST FOR SUCH INFORMATION AT THE FOLLOWING
ADDRESS: 555 MADISON AVENUE., 5TH FLOOR, NEW YORK, NY 10022.

 

NEITHER THE ISSUANCE NOR SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II)
UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

	Principal
Amount: $400,000	Issue
Date: November 18, 2021

 

 

SENIOR SECURED CONVERTIBLE PROMISSORY
NOTE

 

For value received, SENTIENT
BRANDS HOLDINGS INC., a Nevada corporation, (referred to hereinafter as the “Borrower”), hereby
promises to pay to the order of LEONITE FUND I, LP, a Delaware limited partnership, or registered assigns (the “Holder”)
the principal sum of four hundred thousand Dollars ($400,000) (the “Principal Amount”), together with interest
on the Principal Amount, on the dates set forth below or upon acceleration or otherwise, as set forth herein (or
as may be amended, extended, renewed and refinanced, collectively, this “Note”). The “Interest
Rate” shall accrue at a rate equal to ten percent (10%) per annum. In no event shall the Interest Rate exceed the maximum
rate allowed by law; any interest payment which would for any reason be unlawful under applicable law shall be applied to principal.

 

The consideration to the
Borrower for this Note is a payment of Four Hundred Thousand Dollars ($400,000) (the “Consideration”) to be
paid by Holder to Borrower in two tranches (each, a “Tranche”). The first Tranche shall consist of a payment
by Holder to Borrower on the Issue Date of no less than two hundred thousand Dollars ($200,000), from which the Holder shall retain
five thousand dollars ($5,000) to cover its legal fees. A second Tranche consisting of Two Hundred Thousand Dollars ($200,000)
shall be paid by Holder to Borrower not later than thirty (30) days after the payment of the first Tranche.

 

    	 

    	 

    

 

The maturity date (“Maturity
Date”) for each Tranche shall be at the end of the period that begins from the date each Tranche is advanced and ends
twelve (12) months thereafter (such periods each referred to herein as a “Tranche Term”). The principal sum,
as well as interest and other fees shall be due and payable in accordance with the payment terms set forth in Article I herein.
Notwithstanding the foregoing, the Maturity Date for this Note and all Tranches advanced hereunder, shall be no later than the
date upon which the Borrower completes an underwritten registered public offering of Common Shares (as defined below). Subject
to Section 5.9 below, this Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein.

 

Any amount of principal,
interest, other amounts due hereunder or penalties on this Note, which is not paid by the due date as specified herein, shall bear
interest at the lesser of the rate of twenty two percent (22%) per annum or the maximum legal amount permitted by law, from the
due date thereof until the same is paid (“Default Interest”).

 

If any payment (other than
a payment due at maturity or upon default) is not made on or before its due date, the Holder may at its discretion collect a delinquency
charge equal to the greater of one hundred dollars ($100.00) or five (5%) percent of the unpaid amount. The unpaid balances on
all obligations payable by Borrower and due to Holder pursuant to the terms of this Note, shall in addition to other remedies contained
herein, bear interest after default or maturity at an annual rate equal to the Default Interest rate.

 

Except as provided for
in Section 1.2.1 below, all payments of principal and interest due hereunder (to the extent not converted into Borrower’s
common stock (the “Common Shares”) shall be paid by automatic debit, wire transfer, check or in coin or currency
which, at the time or times of payment, is the legal tender for public and private debts in the United States of America and shall
be made at such place as Holder or the legal holder or holders of the Note may from time to time appoint in a payment invoice or
otherwise in writing, and in the absence of such appointment, then at the offices of Holder at such address as the Holder shall
hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Unless otherwise agreed or
required by applicable law, payments will be applied first to any accrued unpaid interest, then to any late charges, and then to
principal. Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a business day, the
same shall instead be due on the next succeeding day which is a business day and, in the case of any interest payment date which
is not the date on which this Note is paid in full, interest shall continue to accrue during such extension. As used in this Note,
the term “business day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks
in the city of New York, New York are authorized or required by law or executive order to remain closed.

 

It is further
acknowledged and agreed that the Principal Amount owed by Borrower under this Note shall be increased by the amount of all reasonable
expenses incurred by the Holder in connection with the collection of amounts due, or enforcement of any terms pursuant to, this
Note. All such expenses shall be deemed added to the Principal Amount hereunder to the extent such expenses are paid or incurred
by the Holder.

 

    	2

    	 

    

 

This Note shall be a senior
secured obligation of the Borrower, with first priority over all current and future Indebtedness (as defined below) of the Borrower
and any subsidiaries, whether such subsidiaries exist on the Issue Date or are created or acquired thereafter (each a “Subsidiary”
and collectively, the “Subsidiaries”), except with regard to the balance due to Holder pursuant to the Note
issued by Borrower to Holder dated April 27, 2021, with which this Note shall be secured on a pari passu basis. The obligations
of the Borrower under this Note are secured pursuant to the terms of the security and pledge agreement (the “Security
and Pledge Agreement”) of even date herewith by and between the Borrower and the Holder, terms of which are incorporated
by reference and made part of this Note. With respect to any Subsidiary created or acquired subsequent to the Issue Date, Borrower
agrees to cause such Subsidiary to execute any documents or agreements that would bind the Subsidiary to the terms herein and in
the Related Documents (defined below).

 

This Note is issued by
the Borrower to the Holder pursuant to the terms of that certain Securities Purchase Agreement even date herewith (the “Purchase
Agreement” and collectively with the Security and Pledge Agreement, the “Related Documents”), terms
of which are incorporated by reference and made part of this Note. Each capitalized term used herein, and not otherwise defined,
shall have the meaning ascribed thereto in the Purchase Agreement. As used herein, the term “Trading Day” means any
day that the Common Shares are listed for trading or quotation on OTC Markets, or any other exchanges or electronic quotation systems
on which the Common Shares are then traded (as defined in the Purchase Agreement).

 

This Note is free from
all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other
similar rights of shareholders or members, as applicable, of Borrower and will not impose personal liability upon the holder thereof.

 

In addition to the terms above, the following
terms shall also apply to this Note:

 

ARTICLE I. PAYMENTS

 

1.1               
Principal Payments. The Principal
Amount shall be due and payable on the Maturity Date.

 

1.2               
Interest. Interest on this Note (i) is computed separately for each Tranche; (ii)
compounds monthly (that is, for each month during each Tranche Term, the amount of accrued interest is determined by multiplying
one twelfth (1/12th) of the Interest Rate by the sum of the principal amount plus any accrued and unpaid interest of such Tranche);
(iii) is payable on the Maturity Date; and (iv) is guaranteed to the Holder for the entirety of each Tranche Term, without regard
to an acceleration of the Maturity Date, based on the total Principal Amount of each Tranche, without regard to a reduction of
the Principal Amount resulting from, without limitation, Principal Payments, Conversion (as defined below), or prepayment by Borrower.

 

1.3               
Other Payment Obligations. All payments,
fees, penalties, and other charges, if any, due under this Note shall be payable pursuant to the terms contained herein, but in
any case, shall be payable no later than the Maturity Date.

 

ARTICLE II. CONVERSION RIGHTS

 

    	3

    	 

    

 

2.1             
Conversion Right. The Holder shall have the
right at any time, at the Holder’s option to convert all or any part of the outstanding and unpaid principal amount and accrued
and unpaid interest of this Note into fully paid and non-assessable Common Shares of Borrower or other securities into which such
Common Shares shall hereafter be changed or reclassified (each, a “Conversion Share”) at the conversion price
(the “Conversion Price”) determined as provided herein (a “Conversion”); provided,
however, that in no event shall the Holder be entitled to convert any portion
of this Note in excess of that portion of this Note upon conversion of which the sum of (1) the number of Common Shares beneficially
owned by the Holder and its affiliates (other than Common Shares which may be deemed beneficially owned through the ownership of
the unconverted portion of the Note or the unexercised or unconverted portion of any other security of Borrower subject to a limitation
on conversion or exercise analogous to the limitations contained herein, and, if applicable, net of any shares that may be deemed
to be owned by any person not affiliated with the Holder who has purchased a portion of the Note from the Holder) and (2) the number
of Common Shares issuable upon the conversion of the portion of this Note with respect to which the determination of this proviso
is being made, would result in beneficial ownership by the Holder and its affiliates of more than 4.99% of the outstanding Common
Shares. For purposes of the proviso to the immediately preceding sentence, beneficial ownership shall be determined in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulations
13D-G thereunder, except as otherwise provided in clause (1) of such proviso, provided,
further, however,
that the limitations on conversion may be waived (up to a maximum of 9.99%) by the Holder upon, at the election of the Holder,
not less than 61 days’ prior notice to Borrower, and the provisions of the conversion limitation shall continue to apply
until such 61st day (or such later date, as determined by the Holder, as may be specified in such notice of waiver). The number
of Common Shares to be issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined
below) by the applicable Conversion Price then in effect on the date specified in the notice of conversion, in the form attached
hereto as Exhibit A (the “Notice of Conversion”), delivered
to Borrower by the Holder in accordance with Section 2.4 below; provided that the Notice of Conversion is submitted by facsimile
or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to Borrower before 5:00 p.m., New York,
New York time on such conversion date (the “Conversion Date”). The term “Conversion Amount”
means, with respect to any conversion of this Note, the sum of: (1) the principal amount of this Note to be converted in such conversion;
plus (2) at the Holder’s option, accrued and unpaid interest; provided,
however, that at the option of Holder, the accrued and unpaid interest can be converted prior to any other amounts under the Note,
if any, on such principal amount at the interest rates provided in this Note to the Conversion Date; plus
(3) at the Holder’s option, Default Interest, if any, on the amounts referred to in the immediately preceding clauses (1)
and/or (2); plus (4) the Holder’s expenses relating to a Conversion,
including but not limited to amounts paid by Holder on the Borrower’s transfer agent account; plus
(5) at the Holder’s option, any amounts owed to the Holder pursuant to Sections 2.3 and 2.4(g) hereof. 

 

2.2             
Conversion Price.

 

(a)               
Calculation of Conversion Price. The Conversion
Price shall be $0.30 (the “Fixed Conversion Price”).

 

(b)              
Fixed Conversion Price Adjustments. 

 

    	4

    	 

    

 

(1)                
Intentionally Omitted. 

 

(2)                
Common Share Distributions and Splits. If
Borrower, at any time while this Note is outstanding: (i) pays a distribution on its Common Shares or otherwise makes a distribution
or distributions payable in Common Shares on its Common Shares; (ii) subdivides outstanding Common Shares into a larger (or smaller)
number of shares; or (iii) issues, in the event of a reclassification of shares of Common Shares, any Common Shares of Borrower,
then the Fixed Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding
any treasury shares of Borrower) outstanding immediately before such event and of which the denominator shall be the number of
Common Shares outstanding immediately after such event; provided, however, that it is hereby acknowledged and agreed by Holder
that the Borrower shall have the unilateral right without Holder’s consent to make payments to consultants, service providers,
vendors, employees and directors with Common Shares and
that this provision is not applicable to any such Common Share issuances. 

 

(3)                
Fundamental Transaction. If,
at any time while this Note is outstanding, (i) Borrower effects any merger or consolidation of Borrower with or into another person,
(ii) Borrower effects any sale of all or substantially all of its assets in one transaction or a series of related transactions,
(iii) any tender offer or exchange offer (whether by Borrower or another person) is completed pursuant to which holders of Common
Shares are permitted to tender or exchange their shares for other securities, cash or property, or (iv) Borrower effects any reclassification
of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged
for other securities, cash or property (in any such case, a “Fundamental Transaction”), then, upon any subsequent
conversion of this Note, the Holder shall have the right to receive, for each Conversion Share that would have been issuable upon
such conversion immediately prior to the occurrence of such Fundamental Transaction, the same kind and amount of securities,
cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been,
immediately prior to such Fundamental Transaction, the holder of 1 Common Share (the “Alternate Consideration”).
For purposes of any such conversion, the determination of the Fixed Conversion Price shall be appropriately adjusted to apply to
such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of 1 Common Share in such Fundamental
Transaction, and Borrower shall apportion the Fixed Conversion Price among the Alternate Consideration in a reasonable manner reflecting
the relative value of any different components of the Alternate Consideration.

 

    	5

    	 

    

 

(4)                
Anti-dilution Adjustment. If at any time while
this Note is outstanding, Borrower sells, grants, or otherwise makes a disposition of Common Shares, or sells, grants, or otherwise
makes a disposition of other securities (or in the case of securities existing on the Issue Date, amends such securities) convertible
into, exercisable for, or that would otherwise entitle any person or entity the right to acquire Common Shares, or announces its
intention, or files any document with the SEC or other regulatory body that reflects its intention to do of any of the foregoing,
at an effective price per share that is lower than the then Fixed Conversion Price (such lower price, the “Base Conversion
Price” and such issuances, collectively, a “Dilutive Issuance”) (it being agreed that if the holder
of the Common Shares or other securities so issued shall at any time, whether by operation of purchase price adjustments, reset
provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which
are issued in connection with such issuance, be entitled to receive Common Shares at an effective price per share that is lower
than the Fixed Conversion Price, such issuance shall be deemed to have occurred for less than the Conversion Price on such date
of the Dilutive Issuance, and the Base Conversion Price shall then be adjusted to equal the lowest of such issuance price), then
the Fixed Conversion Price shall be reduced to a price equal the Base Conversion Price as it may be adjusted as provided for above.
Such adjustment shall be made whenever such Common Shares or other securities are issued. Notwithstanding the foregoing, no adjustment
will be made under this Section 2.2(b)(4) in respect of an Exempt Issuance. For purposes of this Section 2.2(b)(4) an “Exempt
Issuance” means an issuance of (a) Common Shares, or (b) other securities of Borrower convertible into or exercisable
or exchangeable for Common Shares (i) upon the exercise or exchange of any securities issued hereunder or under the Warrant and/or
other securities exercisable or exchangeable for or convertible into Common Shares issued and outstanding on the date of this Note,
(ii) to investors of Borrower’s Form 1-A Regulation A Offering Statement which qualified with the SEC on November 1, 2021,
(iii) to Costaldo Law Group P. C. or its assigns, or Grace Court Advisors Inc. or its assigns, (iv) to employees or directors of
Borrower pursuant to any stock or option or similar equity incentive plan duly adopted for such purpose by the Board of Directors
of Borrower, (v) to consultants, service providers, suppliers, or advisors in connection with the provision of goods or services
to Borrower or any of its Subsidiaries at market value as of the date of issuance pursuant to a stock option plan of the Borrower,
agreement, or arrangement duly adopted for such purpose by the Board of Directors of Borrower, (vi) to banks, equipment lessors
or other financial institutions, or to real property lessors, at market value as of the date of issuance pursuant to a debt financing,
equipment leasing or real property leasing transaction approved by the Board of Directors of Borrower, (vii) pursuant to the acquisition
of another corporation or other entity by Borrower by merger, purchase of substantially all of the assets or other reorganization
or pursuant to a joint venture agreement, approved by the Board of Directors of Borrower, provided that any such issuance shall
only be to a person (or to the equity holders of a person) which is, itself or through its subsidiaries, an operating company or
an owner of an asset in a business synergistic with the operating business of Borrower and shall provide to Borrower additional
benefits in addition to the investment of funds, (viii) to third parties in connection with collaboration,
technology license, development, marketing or other similar agreements or strategic partnerships, in each case only in connection
with the operating business of the Borrower, approved by the Board of Directors of Borrower, or (ix) to which the Holder waives
its anti-dilution rights granted hereby; provided, however, that (iv) through (viii) above shall not include a transaction in which
Borrower is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities. In the event of an issuance of securities involving multiple tranches or closings, any adjustment pursuant to this
Section 2.2(b)(4) shall be calculated as if all such securities were issued upon distribution of the initial tranche. 

 

(5)                
Notice to the Holder. Whenever
the Conversion Price is adjusted pursuant to any provision of this Section 2.2(b), Borrower shall within five (5) business days
deliver to the Holder a notice setting forth the Fixed Conversion Price after such adjustment and setting forth a brief statement
of the facts requiring such adjustment, provided that Borrower’s
failure to timely provide the notice shall not affect the automatic adjustments contemplated hereby. 

 

    	6

    	 

    

 

2.3             
Authorized Shares. Borrower covenants that
during the period the conversion right exists, Borrower will reserve from its authorized and unissued Common Shares a sufficient
number of shares, free from preemptive rights, to provide for the issuance of Common Shares upon the full conversion of this Note
and exercise of the Warrant. Borrower is required at all times to have authorized and reserved seven (7) times the number of shares
that is actually issuable upon full conversion of the Note (based on the Conversion Price of the Note in effect from time to time,
which, if cannot be determined shall be estimated in good faith by Borrower) it being acknowledged and agreed by the parties that
for the initial issuance of the Note, 10,500,000 shares of Common
Shares is sufficient and will be reserved (the “Reserved Amount”). The Reserved Amount shall be increased from
time to time in accordance with Borrower’s obligations hereunder. Borrower represents that upon issuance, such shares will
be duly and validly issued, fully paid and non-assessable. In addition, if Borrower shall issue any securities or make any change
to its capital structure which would change the number of Common Shares into which the Note shall be convertible at the then current
Conversion Price, Borrower shall at the same time make proper provision so that thereafter there shall be a sufficient number of
Common Shares authorized and reserved, free from preemptive rights, for conversion of the outstanding Note, including but not limited
to authorizing additional shares or effectuating a reverse split. Borrower (i) acknowledges that it has irrevocably instructed
its transfer agent by letter, a copy of which is attached hereto as Exhibit B
to issue certificates for the Common Shares issuable upon conversion of this Note and exercise of the Warrant, and (ii) agrees
that its issuance of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing
Common Share certificates to execute and issue the necessary certificates for Common Shares in accordance with the terms and conditions
of this Note. If, at any time Borrower does not maintain the Reserved Amount it will be considered an Event of Default under Section
3.2 of the Note.

 

2.4             
Method of Conversion.

 

(a)               
Mechanics of Conversion. Subject to Section
2.1, this Note may be converted by the Holder in whole or in part, at any time from the date hereof, by (A) submitting to Borrower
a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion Date prior
to 5:00 p.m., New York, New York time) and (B) subject to Section 2.4(b), surrendering this Note at the principal office of Borrower.

 

(b)              
Surrender of Note Upon Conversion. Notwithstanding
anything to the contrary set forth herein, upon conversion of this Note in accordance with the terms hereof, the Holder shall not
be required to physically surrender this Note to Borrower unless the entire unpaid principal amount of this Note is so converted.
The Holder and Borrower shall maintain records showing the principal amount so converted and the dates of such conversions or shall
use such other method, reasonably satisfactory to the Holder and Borrower, so as not to require physical surrender of this Note
upon each such conversion. In the event of any dispute or discrepancy, such records of Borrower shall, prima facie, be controlling
and determinative in the absence of manifest error. The Holder and any assignee, by acceptance of this Note, acknowledge and agree
that, by reason of the provisions of this paragraph, following conversion of a portion of this Note, the unpaid and unconverted
principal amount of this Note represented by this Note may be less than the amount stated on the face hereof.

 

    	7

    	 

    

 

(c)               
Payment of Taxes. Borrower shall not be required
to pay any tax which may be payable in respect of any transfer involved in the issue and delivery of Common Shares or other securities
or property on conversion of this Note in a name other than that of the Holder (or in street name), and Borrower shall not be required
to issue or deliver any such shares or other securities or property unless and until the person or persons (other than the Holder
or the custodian in whose street name such shares are to be held for the Holder’s account) requesting the issuance thereof
shall have paid to Borrower the amount of any such tax or shall have established to the satisfaction of Borrower that such tax
has been paid.

 

(d)              
Delivery of Common Shares Upon Conversion.
Upon receipt by Borrower from the Holder of a facsimile transmission or e-mail (or other reasonable means of communication) of
a Notice of Conversion meeting the requirements for conversion as provided in this Section 2.4, Borrower shall timely issue and
cause to be delivered by the Borrower’s transfer agent to or upon the order of the Holder certificates for Common Shares
issuable upon such conversion within four (4) business days after such receipt (the “Deadline”) (and, solely
in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof.

 

(e)               
Obligation of Borrower to Deliver Common Shares.
Upon receipt by Borrower of a Notice of Conversion, the Holder shall be deemed to be the holder of record of the Common Shares
issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on this Note shall
be reduced to reflect such conversion, and, unless Borrower defaults on its obligations under this Article II, all rights with
respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Shares
or other securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion
as provided herein, Borrower’s obligation to issue and cause to be delivered by the Borrower’s transfer agent the certificates
for Common Shares shall be absolute and unconditional, irrespective of the absence of any action by the Holder to enforce the same,
any waiver or consent with respect to any provision thereof, the recovery of any judgment against any person or any action to enforce
the same, any failure or delay in the enforcement of any other obligation of Borrower to the holder of record, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder of any obligation to Borrower, and irrespective
of any other circumstance which might otherwise limit such obligation of Borrower to the Holder in connection with such conversion.
The Conversion Date specified in the Notice of Conversion shall be the Conversion Date so long as the Notice of Conversion is received
by Borrower before 9:00 p.m., New York, New York time, on such date.

 

(f)               
Delivery of Common Shares by Electronic Transfer.
In lieu of delivering physical certificates representing the Common Shares issuable upon conversion, provided Borrower is participating
in the Depository Trust Company (“DTC”) Fast Automated Securities Transfer (“FAST”) program,
upon request of the Holder and its compliance with the provisions contained in Section 2.1 and in this Section 2.4, Borrower shall
use its best efforts to cause its transfer agent to electronically transmit the Common Shares issuable upon conversion to the Holder
by crediting the account of Holder’s Prime Broker with DTC through its Deposit Withdrawal Agent Commission (“DWAC”)
system. If the Borrower is not registered with DTC as of the Issue Date, the Borrower shall be required to register with DTC within
30 days of the Issue Date, and the provisions of this paragraph shall apply after such registration. Failure to become DTC registered
as provided herein shall be an Event of Default under Section 4.22 of this Note.

 

    	8

    	 

    

 

(g)              
Failure to Deliver Common Shares Prior to Deadline.
Without in any way limiting the Holder’s right to pursue other remedies, including actual damages and/or equitable relief,
the parties agree that if Borrower causes the Common Shares issuable upon conversion of this Note to not be delivered by the Deadline
(other than a failure due to the circumstances described in Section 2.3 above, which failure shall be governed by such Section)
Borrower shall pay to the Holder $250 per day in cash, for each day beyond the Deadline that Borrower fails to deliver such Common
Shares. Such cash amount shall be paid to Holder by the fifth day of the month following the month in which it has accrued or,
at the option of the Holder (by written notice to Borrower by the first day of the month following the month in which it has accrued),
shall be added to the principal amount of this Note, in which event interest shall accrue thereon in accordance with the terms
of this Note and such additional principal amount shall be convertible into Common Shares in accordance with the terms of this
Note. Borrower agrees that the right to convert is a valuable right to the Holder, and as such, Borrower will not take any actions
to hamper, delay or prevent any Holder conversion of the Note. The damages resulting from a failure, attempt to frustrate, interference
with such conversion right are difficult if not impossible to qualify. Accordingly, the parties acknowledge that the liquidated
damages provision contained in this Section 2.4(g) are justified. 

 

2.5             
Concerning the Common Shares. The Common Shares
issuable upon conversion of this Note may not be sold or transferred unless (i) such shares are sold pursuant to an effective registration
statement under the Act or (ii) Borrower’s transfer agent shall have been furnished with an opinion of counsel (which opinion
shall be in form, substance and scope customary for opinions of counsel in comparable transactions) to the effect that the shares
to be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares are sold
or transferred pursuant to Rule 144 under the Act (or a successor rule) (“Rule 144”) or (iv) such shares are
transferred to an “affiliate” (as defined in Rule 144) of Borrower who agrees to sell or otherwise transfer
the shares only in accordance with this Section 2.5 and who is an Accredited Investor. Except as otherwise provided (and subject
to the removal provisions set forth below), until such time as the Common Shares issuable upon conversion of this Note have been
registered under the Act or otherwise may be sold pursuant to Rule 144 without any restriction as to the number of securities as
of a particular date that can then be immediately sold, each certificate for Common Shares issuable upon conversion of this Note
that has not been so included in an effective registration statement or that has not been sold pursuant to an effective registration
statement or an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:

 

    	9

    	 

    

 

NEITHER THE ISSUANCE AND SALE OF THE
SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE ACCEPTABLE TO THE COMPANY), IN A GENERALLY ACCEPTABLE
FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
SECURED BY THE SECURITIES.

 

The legend set forth above shall be removed
and Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if (i) Borrower or its transfer
agent shall have received an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions,
to the effect that a public sale or transfer of such Common Shares may be made without registration under the Act, which opinion
shall be accepted by Borrower (which acceptance shall be subject to and conditioned on any requirements, if any, of the its transfer
agent, the exchange on which Borrower is then trading or other applicable laws, rules or regulations) so that the sale or transfer
is effected or (ii) in the case of the Common Shares issuable upon conversion of this Note, such security is registered for sale
by the Holder under an effective registration statement filed under the Act or otherwise may be sold pursuant to Rule 144 without
any restriction as to the number of securities as of a particular date that can then be immediately sold. In the event that Borrower
does not accept the opinion of counsel provided by the Holder with respect to the transfer of Securities pursuant to an exemption
from registration, such as Rule 144 or Regulation S, at the Deadline, it will be considered an Event of Default pursuant to Section
4.2 of the Note; provided that notwithstanding the foregoing, if Borrower is legally unable to accept such opinion as a result
of any of Borrower’s transfer agent requirements, the requirements of the exchange on which Borrower is then traded, or other
applicable laws, rules or regulations, Borrower’s non-acceptance shall be an Event of Default pursuant to Section 4.25.

 

2.6             
Status as Shareholder. Upon submission of
a Notice of Conversion by Holder, (i) the shares covered thereby (other than the shares, if any, which cannot be issued because
their issuance would exceed such Holder’s allocated portion of the Reserved Amount or Maximum Share Amount) shall be deemed
converted into Common Shares and (ii) the Holder’s rights as a Holder of such converted portion of this Note shall cease
and terminate, excepting only the right to receive certificates for such Common Shares and to any remedies provided herein or otherwise
available at law or in equity to such Holder because of a failure by Borrower to comply with the terms of this Note. Notwithstanding
the foregoing, if a Holder has not received certificates for all Common Shares prior to the tenth (10th) business day after the
expiration of the Deadline with respect to a conversion of any portion of this Note for any reason, then (unless the Holder otherwise
elects to retain its status as a holder of Common Shares by so notifying Borrower) the Holder shall regain the rights of a Holder
of this Note with respect to such unconverted portions of this Note and Borrower shall, as soon as practicable, return such unconverted
Note to the Holder or, if the Note has not been surrendered, adjust its records to reflect that such portion of this Note has not
been converted. In all cases, the Holder shall retain all of its rights and remedies (including, without limitation, (i) the right
to receive Conversion Default Payments pursuant to Section 2.3 to the extent required thereby for such Conversion Default and any
subsequent Conversion Default and (ii) the right to have the Conversion Price with respect to subsequent conversions determined
in accordance with Section 2.3) for Borrower’s failure to convert this Note.

 

    	10

    	 

    

 

ARTICLE III. RANKING, CERTAIN COVENANTS AND
POST CLOSING OBLIGATIONS

  

3.1             
Warrant. Borrower shall issue to the Holder
a common share purchase warrant (the “Warrant”), exercisable for 666,667 of the Borrower’s Common Shares,
on the Final Closing Date (as defined in the Purchase Agreement). The Warrant shall have a term of five (5) years, and an exercise
price of forty five cents ($0.45) per share, and shall contain full-ratchet anti-dilution protection provisions.

 

3.2             
Intentionally Omitted. 

 

3.3             
Distributions on Common Shares. So long as
the Borrower shall have any obligation under this Note, the Borrower shall not without the Holder’s written consent (a) pay,
declare or set apart for such payment, any dividend or other distribution (whether in cash, property or other securities) on the
Common Shares (or other capital securities of the Borrower) other than dividends on Common Shares solely in the form of additional
Common Shares or (b) directly or indirectly or through any Subsidiary make any other payment or distribution in respect of Common
Shares (or other securities representing its capital) except for distributions that comply with Section 3.7 below; provided, however,
that it is hereby acknowledged and agreed by Holder that the Borrower shall have the unilateral right without Holder’s consent
to make payments to consultants, service providers, vendors, employees and directors with Common Shares and that this provision
is not applicable to any such Common Share issuances.

 

3.4             
Restrictions on Certain Transactions. With
the exception of an Exempt Issuance, unless approved by the Holder, Borrower and each Subsidiary shall not subsequent to the Initial
Closing Date (as defined in the Purchase Agreement) enter into an agreement or amend an existing
agreement to effect any sale of securities involving, or convert any securities previously issued under, a Variable Rate Transaction.
The term “Variable Rate Transaction” means a transaction in which Borrower or any Subsidiary (i) issues or sells
any convertible securities either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies
with the trading prices of, or quotations for, the Common Shares at any time after the initial issuance of such convertible securities,
or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance
of such convertible securities or upon the occurrence of specified or contingent events directly or indirectly related to the business
of Borrower or the Subsidiary, as the case may be, or the market for the Common Shares,
or (ii) enters into any agreement (including, without limitation, an “equity line of credit” or an “at-the-market
offering”) whereby Borrower or any Subsidiary may sell securities at a future determined price (other than standard and customary
“preemptive” or “participation” rights). The Holder shall be entitled to obtain injunctive relief against
Borrower and its Subsidiaries to preclude any such issuance, which remedy shall be in addition to any right to collect damages.

 

    	11

    	 

    

 

3.5               
Restrictions on Other Certain Transactions.
So long as the Borrower shall have any obligation under this Note and unless approved in writing by the Holder (which such approval
not to be unreasonably withheld), the Borrower shall not directly or indirectly: (a) change the nature of its business; (b) sell,
divest, change the structure of any material assets of the Borrower or any Subsidiary other than in the ordinary course of business;
or (c) accept Merchant-Cash-Advances or similar financing instruments.

 

3.6               
Restriction on Common Share Repurchases. So
long as the Borrower shall have any obligation under this Note, Borrower shall not without the Holder’s written consent redeem,
repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction
or series of related transactions any Common Shares (or other securities representing its capital) of Borrower or any warrants,
rights or options to purchase or acquire any such shares; except for the repurchase of shares at a nominal price in connection
with rights under an agreement with an employee or consultant of the Borrower whose shares have been forfeited as a result of such
employee or consultant’s ceasing to provide services to the Borrower.

 

3.7               
Payments from Future Funding Sources.

 

3.7.1          
Future Financing Proceeds - At the Holder’s
discretion, the Borrower shall pay to the Holder on an accelerated basis, any outstanding Principal Amount of the Note, along with
all unpaid interest, and fees and penalties, if any, from the net cash proceeds of any future financing by Borrower or any Subsidiary,
whether debt or equity, or any other financing proceeds such as cash advances, royalties or earn-out payments, provided, however,
that (1) the repayment obligation described herein shall not be applicable to (i) the first $2,000,000 of cash proceeds in the
aggregate, generated by the Borrower from any future financing proceeds, (ii) asset-based loans or lines of credit obtained by
the Borrower, or (iii) transactions generating future financing proceeds with a specific use of proceeds requirement that such
proceeds are to be used exclusively to purchase the assets or equity of an unaffiliated business in an arm’s length transaction
and the proceeds are used accordingly, and (2) in the event of any such future financings or transactions described in Sections
3.7.1(i), (ii), and (iii) above, Borrower shall provide Holder with notice of any such financings or transactions and that such
financings or transactions shall be subject to other applicable terms in this Note including but not limited to Section 3.10, 3.11,
and 3.12.

 

3.7.2          
Asset Sale - At the Holder’s discretion,
the Borrower shall pay to the Holder on an accelerated basis, any outstanding Principal Amount of the Note, along with unpaid interest,
and fees and penalties, if any, from the net proceeds to the Borrower or Subsidiary resulting from the sale of any assets of Borrower
or any of its Subsidiaries, including the sale of any Subsidiary, or receipt by Borrower or any of its Subsidiaries of any tax
credits, or collections pursuant to any settlement or judgement, but not including sales of inventory of the Borrower or its Subsidiaries
in the ordinary course of business. 

 

    	12

    	 

    

 

3.8               
Use of Proceeds. Borrower agrees to use the
proceeds of this Note in accordance with Section 5.3 of the Purchase Agreement.

 

3.9               
Ranking and Security. The obligations of the
Borrower under this Note shall constitute a first priority security interest and rank senior with respect to any and all Indebtedness
existing prior to or incurred as of or following the initial Issue Date except with regard to the balance due to Holder pursuant
to the Note issued by Borrower to Holder dated April 27, 2021, with which this Note shall be secured on a pari passu basis. The
obligations of the Borrower under this Note are secured pursuant to the Security and Pledge Agreement attached hereto. So long
as the Borrower shall have any obligation under this Note, the Borrower shall not (directly or indirectly through any Subsidiary
or affiliate) incur or suffer to exist or guarantee any Indebtedness that is senior to or pari passu with (in priority of payment
and performance) the Borrower’s obligations hereunder. As used herein, the term “Indebtedness” means (a)
all indebtedness of the Borrower for borrowed money or for the deferred purchase price of property or services, including any type
of letters of credit, but not including deferred purchase price obligations in place as of the Issue Date or obligations to trade
creditors incurred in the ordinary course of business, (b) all obligations of the Borrower evidenced by notes, bonds, debentures
or other similar instruments, (c) purchase money indebtedness hereafter incurred by the Borrower to finance the purchase of fixed
or capital assets, including all capital lease obligations of the Borrower which do not exceed the purchase price of the assets
funded, (d) all guarantee obligations of the Borrower in respect of obligations of the kind referred to in clauses (a) through
(c) above that the Borrower would not be permitted to incur or enter into, and (e) all obligations of the kind referred to in clauses
(a) through (d) above that the Borrower is not permitted to incur or enter into that are secured and/or unsecured by (or for which
the holder of such obligation has an existing right, contingent or otherwise, to be secured and/or unsecured by) any lien or encumbrance
on property (including accounts and contract rights) owned by the Borrower, whether or not the Borrower has assumed or become liable
for the payment of such obligation.

 

3.10           
Right of Participation. For a period of eighteen
(18) months from the Initial Closing Date (as defined in the Purchase Agreement), in the event Borrower or any Subsidiary of the
Borrower, proposes to offer and sell its securities, whether debt, equity, or any other financing transaction (each a “Future
Offering”), the Holder shall have the right, but not the obligation, to participate in the purchase of the securities
being offered in such Future Offering up to an amount equal to one hundred percent (100%) of the maximum Principal Amount of this
Note in strict accordance with the terms of such Future Offering.

 

3.11           
Right of First Refusal. If at any time while
this Note is outstanding, the Borrower or any Subsidiary has a bona fide offer of capital or financing from any third party that
the Borrower or any Subsidiary intends to act upon, then the Borrower must first offer such opportunity to the Holder to provide
such capital or financing to the Borrower or Subsidiary on the same terms as each respective third party’s terms. Should
the Holder be unwilling or unable to provide such capital or financing to the Borrower or Subsidiary within ten (10) Trading Days
from Holder’s receipt of written notice of the offer (the “Offer Notice”) from the Borrower, then the
Borrower or Subsidiary may obtain such capital or financing from that respective third party. If the Borrower or Subsidiary does
not receive the capital or financing from the respective third party within 60 days after the date of the respective Offer Notice,
then the Borrower must again offer the capital or financing opportunity to the Holder as described above, and the process detailed
above shall be repeated. The Offer Notice must be sent via electronic mail to avi@leonitecap.com
Cc: dberger@bergerlawpllc.com.

 

    	13

    	 

    

 

3.12           
Terms of Future Financings. So long as this
Note is outstanding, solely in connection with a financing of Borrower and subject to the provisions of this section, upon any
issuance of (or announcement of intent to effect an issuance of) any security, or amendment to (or announcement of intent to effect
an amendment to) any security that was originally issued before the Issue Date, by the Borrower or any Subsidiary, with any term
that in the aggregate with all of the terms in such future financing, is either more favorable to the holder of such security than
the Holder of this Note or in favor of the holder of such security that was not similarly provided to the Holder of this Note,
then (i) the Borrower shall notify the Holder of such more favorable term within five (5) business days of the issuance and/or
amendment (as applicable) of the respective security, and (ii) such term, at Holder’s option, shall become a part of the
transaction documents with the Holder (regardless of whether the Borrower complied with the notification provision of this Section
3.12), provided, however, that this provision is not applicable to (i) Borrower’s Form 1-A Regulation A Offering Statement
which qualified with the SEC on November 1, 2021, (ii) compensation paid by Borrower to Costaldo Law Group P. C. or its assigns,
or Grace Court Advisors Inc. or its assigns, (iii) compensation paid by Borrower to employees or directors of Borrower pursuant
to any stock or option or similar equity incentive plan duly adopted for such purpose by the Board of Directors of Borrower, or
(iv) compensation to consultants, service providers, advisors, or vendors, in connection with the provision of goods or services
to Borrower, paid by Borrower in Common Shares or securities of Borrower at market value as of the date of issuance, pursuant to
a stock option plan of the Borrower, agreement, or arrangement duly adopted for such purpose by the Board of Directors of Borrower.
The types of terms contained in another security that may be more favorable to the holder of such security include, but are not
limited to, terms addressing conversion discounts, prepayment rate, conversion lookback periods, interest rates, original issue
discounts, commitment shares, stock sale price, private placement price per share, and warrant coverage. If Holder elects to have
the term become a part of the Subscription Documents with the Holder, then the Borrower shall immediately deliver acknowledgment
of such adjustment in form and substance reasonably satisfactory to the Holder (the “Acknowledgment”) within 30 days
of Borrower’s receipt of request from Holder (the “Adjustment Deadline”), provided that Borrower’s failure
to timely provide the Acknowledgement shall not affect the automatic amendments contemplated hereby.

 

3.13           
Registration Rights. If the Borrower or any
Subsidiary proposes to register any of its Common Shares (other than pursuant to a Registration on Form S-4 or S-8 or any successor
form), or to issue, sell, grant, or otherwise make a disposition of any of its Common Shares through a filing of Form 1-A, it will
give prompt written notice to the Holder of its intention to effect such registration (the “Incidental Registration”).
Within ten (10) business days of receiving such written notice of an Incidental Registration, the Holder may make a written request
(the “Piggy-Back Request”) that the Borrower include in the proposed Incidental Registration all, or a portion, of
the Registrable Securities owned by the Holder. The Borrower will use its commercially reasonable efforts to include in any Incidental
Registration all Registrable Securities which the Borrower has been requested to register pursuant to any timely Piggy-Back Request
to the extent required to permit the disposition (in accordance with the intended methods thereof as aforesaid) of the Registrable
Securities so to be registered. 

 

    	14

    	 

    

 

3.14           
Rollover Rights. So long as the Note is outstanding,
if the Borrower completes any single public offering or private placement of its equity, equity-linked or debt securities (each,
a “Future Transaction”), the Holder may, elect to apply all, or any portion, of the then outstanding principal amount
of the Note and any accrued but unpaid interest, as purchase consideration for such Future Transaction (the “Rollover Rights”),
provided however, that in the event such Rollover Rights election (i) hinders the Borrower’s ability to close on the contemplated
Future Transaction, or (ii) is rejected by any of the investors in the Future Transaction, such Rollover Rights election may not
be exercised by Holder. The Borrower shall give written notice to Holder as soon as practicable, but in no event less than fifteen
(15) days before the anticipated closing date of such Future Transaction. The Holder may exercise its Rollover Rights by providing
the Borrower written notice of such exercise within five (5) Business Days before the closing of the Future Transaction. In the
event Holder elects to exercise its Rollover Rights, and such Rollover Rights election does not prevent the contemplated Future
Transaction from closing, then such elected portion of the outstanding principal amount of this Note and accrued but unpaid interest
shall automatically convert into the corresponding securities issued in such Future Transaction under the terms of such Future
Transaction. Notwithstanding the foregoing, Borrower may reject all or a portion of Holder’s election under this Section
3.14 by sending a Prepayment Notice to Holder, pursuant to Section 5.9, prior to the closing of the Future Transaction, and by
paying the Note in part or in full as applicable, pursuant to the terms of Section 5.9, except that such payment shall be due no
later than (5) business days after the closing of the Future Transaction. If Borrower does not make a payment pursuant to the Prepayment
Notice within five (5) business days after the closing of the Future Transaction, Borrower shall be required to immediately deliver
to Holder the securities that Holder would have been entitled to pursuant to the Rollover Rights election. No election or notice
under this Section 3.14 shall preclude the Holder from exercising its conversion rights under Article II.

 

3.15           
Exchange Act Reporting. Borrower shall remain
a fully reporting company under the SEC reporting requirements and remain subject to and fully compliant with, the annual and periodic
reporting requirements of the Exchange Act (including but not limited to becoming current in its filings). Failure to remain a
fully reporting company and subject to and compliant with the Exchange Act as described herein, (including but not limited to becoming
delinquent in its filings), shall be an Event of Default (as defined below) under Section 4.9.

 

3.16           
Opinion Letter. At the earlier of (i) six
(6) months or (ii) on the date upon which the Borrower competes an underwritten registered public offering of Common Shares of
the Borrower, the Borrower shall be responsible, for supplying an opinion letter specific to the fact that Common Shares issued
pursuant to conversion of the Note, and the shares issued pursuant to the Warrant, are either exempt from Registration Requirements
pursuant to Rule 144 (so long as the requirements of Rule 144 are satisfied) or have been duly registered on a registration statement
and permitted to be sold and transferred without restriction. 

 

    	15

    	 

    

 

ARTICLE IV. EVENTS OF DEFAULT

 

It shall be considered
an event of default if any of the following events listed in this Article IV (each, an “Event of Default”) shall
occur:

 

4.1Failure
to Pay Principal or Interest. The Borrower fails to pay the principal hereof or interest
thereon when due on this Note, whether at maturity, upon acceleration or otherwise. A three (3) day cure period shall apply for
failure to make a payment when due except where payments are noted herein as being due immediately or for payments due on the Maturity
Date which in each case shall have no cure period. 

 

4.2             
Failure to Reserve Shares. Borrower fails
to reserve a sufficient amount of Common Shares as required under the terms of this Note (including the requirements of Section
2.3 of this Note), fails to issue Common Shares to the Holder (or announces or threatens in writing that it will not honor its
obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with the terms of this Note,
fails to cause its transfer agent to transfer (issue) (electronically or in certificated form) Common Shares issued to the Holder
upon conversion of or otherwise pursuant to this Note as and when required by this Note, Borrower directs its transfer agent not
to transfer or delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated
form) Common Shares to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this
Note, or fails to cause to be removed (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer
agent from removing) any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any Common Shares
issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written
announcement, statement or threat that it does not intend to honor the obligations described in this paragraph), or fails to supply
an opinion letter specific to the fact that Common Shares issued pursuant to conversion of the Note, and the shares issued pursuant
to the Warrant are either exempt from Registration Requirements pursuant to Rule 144 or have been duly
registered on a registration statement, assuming that Borrower’s counsel opines that the Rule 144 conditions or the
registration requirements, as applicable, have been satisfied, and any such failure shall continue uncured (or any written announcement,
statement or threat not to honor its obligations shall not be rescinded in writing) for three (3) business days after the Holder
shall have delivered a Notice of Conversion. It is an obligation of Borrower to remain current in its obligations to its transfer
agent. It shall be an event of default of this Note, if a conversion of this Note is delayed, hindered or frustrated due to a balance
owed by Borrower to its transfer agent. If at the option of the Holder, the Holder advances any funds to Borrower’s transfer
agent in order to process a conversion, such advanced funds shall be paid by Borrower to the Holder within five (5) business days
of a demand from the Holder, either in cash or as an addition to the outstanding Principal Amount of the Note, and such choice
of payment method is at the discretion of Borrower.

 

4.3             
Breach of Covenants. Borrower, or the relevant
related party, as the case may be, breaches any material covenant, post-closing obligation or other material term or condition
contained in this Note, or in the related Warrant, Purchase Agreement, Security and Pledge Agreement, Term Sheet or any other collateral
documents (together, the “Transaction Documents”) and breach continues for a period of 30 days without being
cured. 

 

    	16

    	 

    

 

4.4             
Breach of Representations and Warranties.
Any representation or warranty of the Borrower made herein or in any agreement, statement or certificate given pursuant hereto
or in connection herewith, shall be false or misleading in any material respect when made and the breach of which has (or with
the passage of time will have) an effect on the rights of the Holder with respect to this Note and the other Transaction Documents.

 

4.5             
Receiver or Trustee. Borrower or any subsidiary
of Borrower shall make an assignment for the benefit of creditors, or apply for or consent to the appointment of a receiver or
trustee for it or for a substantial part of its property or business, or such a receiver or trustee shall otherwise be appointed.

 

4.6             
Judgments or Settlements. (i) Any money judgment,
writ or similar process shall be entered or filed against Borrower or any subsidiary of Borrower or any of its property or other
assets for more than $500,000, and shall remain unvacated, unbonded or unstayed for a period of 90 days; or (ii) the delinquency
of an obligation of the Borrower in an amount over $500,000, incurred in connection with a settlement of any claim or litigation,
that remains uncured for a period of 90 days, in each case unless otherwise consented to by the Holder.

 

4.7             
Bankruptcy. Bankruptcy, insolvency, reorganization
or liquidation proceedings or other proceedings, voluntary or involuntary, for relief under any bankruptcy law or any law for the
relief of debtors shall be instituted by or against Borrower or any subsidiary of Borrower. With respect to any such proceedings
that are involuntary, Borrower shall have a 90 day cure period in which to have such involuntary proceedings dismissed. 

 

4.8             
Delisting of Common Shares. If at any time
on or after the date in which Borrower’s Common Shares are listed or quoted on OTC Markets or an equivalent U.S. replacement
trading platform, the Nasdaq Global Market, the Nasdaq Capital Market, the New York Stock Exchange, or the NYSE MKT, Borrower shall
fail to maintain the listing or quotation of the Common Shares, or if its shares have been suspended from trading on OTC Markets
or a U.S. equivalent replacement trading platform, the Nasdaq Global Market, the Nasdaq Capital Market, the New York Stock Exchange,
or the NYSE MKT.

 

4.9             
Failure to Comply with the Exchange Act. Borrower
shall fail to be fully compliant with, or cease to be subject to, the reporting requirements of the Exchange Act (including but
not limited to becoming delinquent in its filings) for 30 consecutive days until such time that such delinquency has been cured.

 

4.10         
Liquidation. Any dissolution, liquidation,
or winding up of Borrower or any substantial portion of its business.

 

4.11         
Cessation of Operations. Any cessation of
operations by the Borrower or the Borrower admits it is otherwise generally unable to pay its debts as such debts become due, provided,
however, that any disclosure of the Borrower’s ability to continue as a “going concern” shall not be considered
a cessation of operations by the Borrower or an admission that the Borrower cannot pay its debts as they become due.

 

    	17

    	 

    

 

4.12         
Maintenance of Assets. The failure by Borrower
to maintain any intellectual property rights, personal, real property or other assets which are necessary to conduct its business
(whether now or in the future), to the extent that such failure would result in a material adverse condition or material adverse
change in or affecting the business operations, properties or financial condition of Borrower or any of its subsidiaries (a “Material
Adverse Effect”).

 

4.13         
Financial Statement Restatement. Borrower
restates any financial statements for any date or period from two years prior to the Issue Date of this Note and until this Note
is no longer outstanding, if the result of such restatement would, by comparison to the unrestated financial statement, have constituted
a material adverse effect on the rights of the Holder with respect to this Note.

 

4.14         
Failure to Execute Transaction Documents or Complete the Transaction.
The failure of the Borrower to execute any of the Transaction Documents or to complete the transaction for the full Principal Amount
of the Note, as contemplated by the Purchase Agreement. 

 

4.15         
Illegality. Any court of competent jurisdiction
issues an order declaring this Note, any of the other Transaction Documents or any provision hereunder or thereunder to be illegal,
as long as such declaration was not the result of an act of negligence by the Holder, exclusive of the execution of the Transaction
Documents or the transactions and acts contemplated herein.

 

4.16         
Cross-Default. Notwithstanding anything to
the contrary contained in this Note or the other related or companion documents, a breach or default by the Borrower of any covenant
or other term or condition contained in any other financial instrument, including but not limited to all promissory notes, currently
issued, or hereafter issued, by the Borrower, to the Holder or any other third party (the “Other Agreements”),
after the passage of all applicable notice and cure or grace periods, that results in a Material Adverse Effect shall, at the option
of the Holder, be considered a default under this Note, in which event the Holder shall be entitled to apply all rights and remedies
of the Holder under the terms of this Note by reason of a default under said Other Agreement or hereunder.

 

4.17         
Variable Rate Transactions. The Borrower (i)
enters into a Variable Rate Transaction (as defined herein) (ii) issues Common Shares (or convertible securities or purchase rights)
pursuant to an equity line of credit of the Borrower or otherwise in connection with a Variable Rate Transaction (whether now existing
or entered into in the future) or (iii) adjusts downward the “floor price” at which Common Shares (or convertible securities
or purchase rights) may be issued under an equity line of credit or otherwise in connection with a Variable Rate Transaction (whether
now existing or entered into in the future).

 

4.18         
Certain Transactions. Borrower enters into
certain transactions prohibited by Sections 3.3, 3.4, 3.5, and 3.6 of this Agreement. 

 

4.19         
Reverse Splits. The Borrower effectuates a
reverse split of its Common Shares without providing 20 days prior written notice of such imminent reverse split to the Holder.

 

    	18

    	 

    

 

4.20         
Replacement of Transfer Agent. In the event
that the Borrower proposes to replace its transfer agent, the Borrower fails to provide, prior to the effective date of such replacement,
a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to the Purchase Agreement (including
but not limited to the provision to irrevocably reserve Common Shares in the Reserved Amount) signed by the successor transfer
agent to Borrower and the Borrower.

 

4.21         
DTC “Chill”. The DTC places a
“chill” (i.e. a restriction placed by DTC on one or more of DTC’s services, such as limiting a DTC participant’s
ability to make a deposit or withdrawal of the security at DTC) on any of the Borrower’s securities.

 

4.22         
DWAC Eligibility. In addition to the Event
of Default in Section 4.21, the Common Shares are otherwise not eligible for trading through the DTC’s Fast Automated Securities
Transfer or Deposit/Withdrawal at Custodian programs, or the Borrower fails to become DTC registered within 30 days of the Issue
Date.

 

4.23         
Bid Price. The Borrower shall lose the “bid”
price for its Common Shares ($0.0001 on the “Ask” with zero market makers on the “Bid” per Level 2) and/or
a market (including the OTC Pink, OTCQB or an equivalent replacement marketplace or trading platform).

 

4.24         
Inside Information. Any attempt by the Borrower
or its officers, directors, and/or affiliates to transmit, convey, disclose, or any actual transmittal, conveyance, or disclosure
by the Borrower or its officers, directors, and/or affiliates of, material non-public information concerning the Borrower, to the
Holder or its successors and assigns, which is not immediately cured by Borrower’s filing of a Form 8-K pursuant to Regulation
FD on that same date.

 

4.25         
Unavailability of Rule 144. If, at any time
on or after the date which is six (6) months after the Issue Date, the Holder is unable to (i) obtain a standard “144 legal
opinion letter” from an attorney reasonably acceptable to the Holder, the Holder’s brokerage firm (and respective clearing
firm), and the Borrower’s transfer agent in order to facilitate the Holder’s conversion of any portion of the Note
into free trading shares of the Borrower’s Common Shares pursuant to Rule 144, and/or (ii) thereupon deposit such shares
into the Holder’s brokerage account.

 

4.26         
Failure to Register. Failure to register the
Registrable Securities pursuant to Section 3.13.

 

4.27         
Remedies Upon Default.

 

(a)               
Upon the occurrence of any Event of Default specified in this Article IV, in addition to and
without limitation of other remedies set forth herein in this Note, (i) interest shall accrue at the Default Interest rate; and
(ii) this Note shall become immediately due and payable, all without demand, presentment or notice, all of which are hereby expressly
waived by the Borrower, and the Borrower shall pay to the Holder, an amount (the “Default Amount”) equal to the Principal
Amount then outstanding plus accrued and unpaid interest through the date of the Event of Default, unaccrued
interest through the remainder of the Note Term, together with all costs, including, without limitation, legal fees and
expenses of collection, and Default Interest through the date of full repayment. In addition,
the Holder shall be entitled to exercise all other rights and remedies available at law or in equity, including, without limitation,
those set forth in the Related Documents.

 

    	19

    	 

    

 

(b)              
Upon the occurrence and during the continuation of an Event of Default, Borrower shall incur
a monthly monitoring fee (“Monitoring Fee”) in the amount of five thousand Dollars ($5,000) per month commencing in
the month in which the Event of Default occurs and continuing until the Event of Default is cured in order to cover the Holder’s
costs of monitoring and legal expenses and other expenses incurred by Holder. 

 

ARTICLE V. MISCELLANEOUS

 

5.1             
Failure or Indulgence Not Waiver. No failure
or delay on the part of the Holder in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of
any other right, power or privileges. All rights and remedies existing hereunder are cumulative to, and not exclusive of, any rights
or remedies otherwise available.

 

5.2             
Notices. All notices, demands, requests, consents,
approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein,
shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid,
(iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, facsimile,
or electronic mail addressed as set forth below or to such other address as such party shall have specified most recently by written
notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery,
upon electronic mail delivery, or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine,
at the address or number designated below (if delivered on a business day during normal business hours where such notice is to
be received), or the first business day following such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for
such communications shall be:

 

If to the Borrower, to:

 

Sentient Brands Holdings Inc.

555 Madison Avenue, 5th Floor 

New York, NY 10022

ATTN: George Furlan 

e-mail:
george@sentientbrands.com

cc:
duke@gracecourtadvisors.com; evan@costaldolaw.com

 

    	20

    	 

    

 

If to the Holder:

 

LEONITE FUND I, LP 

1 Hillcrest Center Dr., Suite 232

Spring Valley, NY 10977 

ATTN: Avi Geller

e-mail:
avi@leonitecap.com  

Cc:
Siegfied@leonitecap.com; jake@leonitecap.com;
dberger@bergerlawpllc.com 

 

5.3             
Amendments. This Note and any provision hereof
may only be amended by an instrument in writing signed by the Borrower and the Holder. The term “Note” and all
reference thereto, as used throughout this instrument, shall mean this instrument as originally executed, or if later amended or
supplemented, then as so amended or supplemented.

 

5.4             
Assignability. This Note shall be binding
upon the Borrower and its successors and assigns, and shall inure to be the benefit of the
Holder and its successors and assigns. Each transferee of this Note must be an “accredited investor” (as defined
in Rule 501(a) of the 1933 Act). 

 

5.5             
Cost of Collection. If default is made in
the payment of this Note, the Borrower shall pay the Holder hereof costs of collection, including attorneys’ fees. Such amounts
spent by Holder shall be added to the Principal Amount of the Note at the time of such expenditure.

 

5.6             
Governing Law. This this Note shall be governed
by and construed in accordance with the laws of the State of Delaware without regard to principles of conflicts of laws. Any action
brought by either party against the other concerning the transactions contemplated by this Note shall be brought only in the state
and/or federal courts located in Delaware. The parties to this Note hereby irrevocably waive any objection to jurisdiction and
venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon
forum non conveniens. THE BORROWER IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL
FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS NOTE OR ANY TRANSACTIONS CONTEMPLATED
HEREBY. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs.
In the event that any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party
hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in
connection with this Agreement or any other Transaction Documents by mailing a copy thereof via registered or certified mail or
overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and
agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. 

 

    	21

    	 

    

 

5.7             
Certain Amounts. Whenever pursuant to this
Note the Borrower is required to pay an amount in excess of the outstanding principal amount (or the portion thereof required to
be paid at that time) plus accrued and unpaid interest plus Default Interest on such interest, the Borrower and the Holder agree
that the actual damages to the Holder from the receipt of cash payment on this Note may be difficult to determine and the amount
to be so paid by the Borrower represents stipulated damages and not a penalty.

 

5.8             
Remedies. The Borrower acknowledges that a
breach by it of its obligations hereunder will cause irreparable harm to the Holder, by vitiating the intent and purpose of the
transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at law for a breach of its obligations
under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the Borrower of the provisions
of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in equity, and in addition
to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Note and
to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without any bond or
other security being required.

 

5.9             
Prepayment. Unless an Event of Default shall
occur, Borrower shall have the right at any time prior to the Maturity Date, upon five (5) business day’s e-mail notice to
the Holder (the “Prepayment Notice”), to prepay the Note by making a payment to Lender equal to 105% multiplied by
the sum of (i) the outstanding Principal Amount, (ii) all accrued and unpaid interest, (iii) all unaccrued interest through the
remainder of the Term that is guaranteed pursuant to Section 1.2 above, and (iv) any other amounts due under the Note. During the
three (3) business days following the day that Borrower provides a Prepayment Notice to Holder (the “Prepayment Notice Date”),
Holder may convert any or all of this Note into Common Shares. If payment pursuant to this Section 5.9 is not made within ten (10)
business days following the Prepayment Notice Date, then such Prepayment Notice shall be null and void and Holder may continue
to convert the Note. For avoidance of doubt, any payments made by Borrower pursuant to an election by Holder under Section 3.7
above or the exchange of securities pursuant to an election by Holder under Section 3.14 above, shall not be considered a prepayment
under this Section 5.9.

 

5.10         
Usury. To the extent it may lawfully do so,
the Borrower hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to
be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection
with any action or proceeding that may be brought by the Holder in order to enforce any right or remedy under this Note. Notwithstanding
any provision to the contrary contained in this Note, it is expressly agreed and provided that the total liability of the Borrower
under this Note for payments which under Delaware law are in the nature of interest shall not exceed the maximum lawful rate authorized
under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of
interest or default interest, or both of them, when aggregated with any other sums which under Delaware law in the nature of interest
that the Borrower may be obligated to pay under this Note exceed such Maximum Rate. It is agreed that if the maximum contract rate
of interest allowed by Delaware law and applicable to this Note is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable
to this Note from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances
whatsoever, interest in excess of the Maximum Rate is paid by the Borrower to the Holder with respect to indebtedness evidenced
by this Note, such excess shall be applied by the Holder to the unpaid principal balance of any such indebtedness or be refunded
to the Borrower, the manner of handling such excess to be at the Holder’s election.

 

    	22

    	 

    

 

5.11         
Section 3(a)(10) Transactions. If at any time
while this Note is outstanding, the Borrower enters into a transaction structured in accordance with, based upon, or related or
pursuant to, in whole or in part, Section 3(a)(10) of the Securities Act, then a liquidated damages charge of 30% of the outstanding
principal balance of this Note at that time, will be assessed and will become immediately due and payable to the Holder, either
in the form of cash payment or as an addition to the balance of the Note, as determined by mutual agreement of the Borrower and
Holder.

 

5.12         
No Broker-Dealer Acknowledgement. Absent a
final adjudication from a court of competent jurisdiction stating otherwise, so long as any obligation of Borrower under this Note
or the other Transaction Documents is outstanding, the Borrower shall not state, claim, allege, or in any way assert to any person,
institution, or entity, that Holder is currently, or ever has been, a broker-dealer under the Securities Exchange Act of 1934.

 

5.13         
Opportunity to Consult with Counsel. The Borrower
represents and acknowledges that it has been provided with the opportunity to discuss and review the terms of this Note and the
other Transaction Documents with its counsel before signing it and that it is freely and voluntarily signing the Transaction Documents
in exchange for the benefits provided herein. In light of this, the Borrower will not contest the validity of Transaction Documents
and the transactions contemplated therein. The Borrower further represents and acknowledges that it has been provided a reasonable
period of time within which to review the terms of the Transaction Documents.

 

5.14         
Intentionally Omitted. 

 

5.15         
Intentionally Omitted. 

 

[signature page to follow]

 

 

    	23

    	 

    

 

IN WITNESS WHEREOF, Borrower has caused
this Note to be signed in its name by its duly authorized officer this November 18, 2021.

 

	SENTIENT
BRANDS HOLDINGS INC.	 
	 	 
	By:	/s/
George Furlan	 
	 	 
	Name:
George Furlan	 
	Title:
Interim Chief Executive Officer	 

 

    	24

    	 

    

 

EXHIBIT A – FORM OF NOTICE OF CONVERSION

 

(See Attached)

 

    	25

    	 

    

 

EXHIBIT B – FORM OF TRANSFER AGENT
INSTRUCTION LETTER

 

(See Attached)

 

26

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]